· Web viewImpact of OCTA on our Understanding of AMD: Biology and Management. UCLA Stein Eye...

DAVID SARRAF, M.D.Birthdate: May 6, 1965

Birthplace: Rochester, New YorkLanguages Spoken: English, French

Marital Status: Married

EDUCATION

1984 – 1986 University of Western OntarioUndergraduate SchoolLondon, Ontario, Canada

1986 – 1990 University of TorontoMedical SchoolToronto, Ontario, Canada

1990 – 1991 The Toronto HospitalInternship YearToronto, Ontario, Canada

1991 – 1993 Jules Stein Eye Institute, UCLAOphthalmology Research FellowshipLos Angeles, California

1993 – 1996 University of Chicago, Pritzker School of MedicineOphthalmology ResidencyChicago, Illinois

1996 – 1997 Moorfields Eye Hospital, University College LondonMedical Retina FellowshipLondon, England

ACADEMIC AND CLINICAL OFFICES HELD

1998 – 2007 ML King Medical Center, CR Drew Univ. School of MedicineAssistant Professor of OphthalmologyLos Angeles, California

1998 – Present Stein Eye Institute, UCLA School of MedicineClinical Professor of OphthalmologyRetinal Disorders and Ophthalmic Genetics DivisionLos Angeles, California

D. Sarraf, 07 2019, of 57

PUBLICATIONS

Abstracts

1. Heathcote JG, Veloudios A, Holmyard D, Sarraf D, Hurwitz JJ. Stone formation in the lacrimal drainage system. Can J Ophthalmol 26:100, 1991.

2. Sarraf D, Lee DA. Iontophoresis of Reactive Black 5 for pulsed dye laser sclerostomy. Invest Ophthalmol Visual Sci 33:2870, 1992.

3. Goldberger S, Sarraf D, Bernstein J, Hurwitz JJ. Involvement of the eyebrow fat pad in Graves’ ophthalmopathy. Amer Soc Ophthalmic Plast Reconst Surg Conference, Fall 1992.

4. Eezzuduemhoi RD, Sarraf D, Wilson MR, Cheng Q, Lee DA, Flowers CA. Aqueous and vitreous concentration of mitomycin following topical administration. Invest Ophthalmol Visual Sci 34:110, 1993.

5. Sarraf D, Equi RA, Holland GN, Yoshizumi MO, Lee DA. Transscleral iontophoresis of Foscarnet. Invest Ophthalmol Visual Sci 34:3910, 1993.

6. Hwang IP, Syn Y, Sarraf D, Goins KM. The effect of Ketorolac in the management of Staphylococcal keratitis in rabbits. Invest Ophthalmol Visual Sci 35:1747, 1994.

7. Dubovy S, Sarraf D, Ramanathan S, Goyal R, Richardson R, Ernest T. Pattern ERG in acquired immune deficiency syndrome. Invest Ophthalmol Visual Sci 36:S318, 1995.

8. Sarraf D, Gin T, Brannon A, Owens SL, Bird A. Long-term drusen study:evaluation of incidence of choroidal neovascular membrane formation. Invest Ophthalmol Visual Sci 38:S18, 1997.

9. Gin T, Sarraf D, Brannon A, Owens SL, Bird A. Prognostic characteristics and natural history of pigment epithelial detachments in age-related macular degeneration. Invest Ophthalmol Visual Sci 38:S93, 1997.

10. Sarraf D, Coleman AL. Comparison of ophthalmoscopy and fundus photography in the grading of diabetic retinopathy. Invest Ophthalmol Visual Sci 40:S305, 1999.

11. Kashyap SR, Sarraf D, Levin SR. Microvascular complications in elderly patients who meet the revised criteria for diabetes mellitus. Diabetes 48:A91, 1999.

12. Sarraf D. Clinical evaluation of choroidal folds. Invest Ophthalmol Visual Sci 42:S430, 2001.

13. Charonis AC, Boyer DS, Novack RL, Engstrom RE, Thomas EL, Chu T, Gallemore RP, Holland GN and the Southern California HIV/Eye Consortium. Short- and

D. Sarraf, 07 2019, of 57

long-term complications after ganciclovir implant surgery in patients with AIDS-related CMV retinitis. Invest Ophthalmol Visual Sci 42:S568, 2001.

14. Sarraf D. Photodynamic therapy of subretinal neovascularization complicating acquired juxtafoveal telangiectasis. Invest Ophthalmol Visual Sci 43:S582, 2002.

15. Sarraf D, Ceron O, Rasheed K, Drenser K. West African Crystalline Maculopathy. XXIII Club Jules Gonin (Montreux), 2002.

16. Salib D, Ferreira C, Sarraf D. Age-related macular degeneration and retinitis pigmentosa in an Hispanic family. Invest Ophthalmol Visual Sci 44:S5089, 2003.

17. Tran MK, Jain A, Abbago M, Sarraf D, Schwartz SD. Detection of retinal crystals by optical coherence tomography. Invest Ophthalmol Visual Sci 45:2004.

18. Quiram P, Moral J, Chen C, Sarraf D. OCT findings of chronic solar maculopathy. Invest Ophthalmol Visual Sci. 45: 2004.

19. Szabo SM, Schmidt-Erfurth U, Sarraf D, Michels R, Potter MJ. Clinical outcomes following treatment of subretinal neovascularization in idiopathic juxtafoveal retinal telangiectasis using photodynalmic therapy with Verteporfin (Visudyne). Invest Ophthalmol Visual Sci. 45: 2004.

20. Sarraf D, Salib D, Jain A. The coexistence of ARMD and RP in three unrelated families. XXIV Club Jules Gonin (Athens), 2004.

21. Sarraf D, Salib DM, Jain A, Quiram PA. The coexistence of ARMD and RP in three unrelated families. Invest Ophthalmol Visual Sci. 46: 2005.

22. Dumars S, Quiram PA, Parwar B, Sarraf D. OCT Findings in Viagra-associated serous macular detachments. Invest Ophthalmol Visual Sci. 46: 2005.

23. Shah S, Sarraf D. Optical coherence tomography imaging of metastatic breast carcinoma to the macula pre and post chemotherapy. Invest Ophthalmol Visual Sci. 46: 2005.

24. Chang L, Shah S, Chen J, Sarraf D. OCT imaging of RPE rips in ARMD after Macugen therapy. Invest Ophthalmol Visual Sci. 47: 2006.

25. Shah S, Chang L, Chen J, Sarraf D. OCT imaging of vitelliform maculopathy in ARMD. Invest Ophthalmol Visual Sci. 47: 2006.

26. Sarraf D, Chang L, Flaxel C, Lauer A. RPE tears associated with pegaptanib treatment in ARMD. XXV Club Jules Gonin and Retina Society (Cape Town), 2006.

27. Mango CW, Gupta A, Sarraf D, Suner I, Friberg T, Scwartz SD. Ultrawidefield Imaging and Angiography of Retinal Dystrophies. Invest Ophtalmol Visual Sci. 48: 2007.

D. Sarraf, 07 2019, of 57

28. Low J, Chen J, Luviano D, Yu F, Sarraf D. Comparison of Diabetic Retinopathy Phenotype Between Hispanics and Blacks. Invest Ophthalmol Visual Sci. 48: 2007.

29. Sarraf D, Chang L, Gonzales C. RPE tears associated with intravitreal antiVEGF therapy. Retina Society (Boston), 2007.

30. Chiang A, Chang L, Yu F, Sarraf D. Predictors of antiVEGF associated RPE tears using FA and OCT analysis. Invest Ophthalmol Visual Sci. 49: 2008.

31. Sarraf D, Chiang A, Chang L, Yu F. Predictors of antiVEGF associated RPE tears using FA and OCT analysis. XXVI Club Jules Gonin (St. Moritz) and Retina Society (Scottsdale), 2008.

32. Kaines A, Tsui I, Sarraf D, and Schwartz SD. Utility of Ultra Wide Field Fluorescein Angiography in Evaluation and Management of Uveitis. Invest Ophthalmol Visual Sci. 50:2009.

33. Reddy S, Chiang A, Yu F, Sarraf D. Long-term outcomes of continued antiVEGF therapy for RPE tears. Retina Congress (New York), 2009.

34. Sarraf D, Reddy S, Chiang A, Yu F. A new classification system for RPE tears. Retina Congress (New York), 2009.

35. Sarraf D, Vyas N, Jain A, Bui A, Kertes P, Freund KB, Chan C. Triamcinolone associated crystalline maculopathy. ASRS (Vancouver), 2010.

36. Sarraf D, Jain A, Reddy S, Chiang A, Chang L, Yu F. A new grading system for RPE tears. Macula Society (Boca Raton), 2011.

37. Beardsley R, Yu F, Sarraf D. Posterior staphyloma and the incidence of macular disease imaged with SD-OCT. Invest Ophthalmol Visual Sci. 52:2011.

38. Chan C, Sarraf D et al. High versus Conventional-dose Ranibizumab for Treating Vascularized Pigment Epithelial Detachments Associated with Age-related Macular Degeneration. Invest Ophthalmol Visual Sci. 52:2011.

39. Sarraf D, Beardsley R. A new grading system for posterior staphyloma and correlation with macular complications including myopic macular schisis. Retina Society (Rome), 09/2011.

40. Sarraf D, Chan C, Abraham P, McCannel CA. Prospective evaluation of the incidence of RPE tears and analysis of the baseline risk factors predisposing to RPE tears in eyes with PED and exudative ARMD. Macula Society (Jerusalem), 06/2012.

41. Varshney N, Jain A, Chan V, and Sarraf D. Underlying Pathologies in Severe Macular Hemorrhage Due to Exudative Age-Related Macular Degeneration. Invest. Ophthalmol. Visual Sci. 53:2012

D. Sarraf, 07 2019, of 57

42. Chan CK, Sarraf D, Abraham P, Nuthi AS, Lin SG, and McCannel CA. Comparing Outcomes of 0.5 vs. 2.0 mg Ranibizumab Treatment in Eyes with Vascularized Pigment Epithelial Detachment based on Lesion Subtypes (Serous Vascularized Pigment Epithelial Detachment vs. Fibrovascular Pigment Epithelial Detachment) associated with AMD. Invest. Ophthalmol. Visual Sci. 53:2012

43. Sarraf D et al. Acute Macular Neuroretinopathy (AMN): New insights into diagnosis, natural history and pathogenesis as revealed by sequential multimodal imaging. ASRS (Las Vegas), 08/2012.

44. Nguyen C, Giaconi J, Sarraf D. Clinical manifestations of inadvertant bortezomib injection. ASRS (Las Vegas), 08/2012.

45. Chan C, Sarraf D, Abraham P. Vascularized pigment epithelial detachment treated with 0.5 mg versus 2 mg ranibizumab: analysis of results based on lesion subtypes. Retina Society (Washington DC), 09/2012.

46. Rahimy E, Freund KB, Sarraf D. Multilayered PEDs with SD OCT imaging. Retina Society (Washington DC), 09/2012.

47. Freund KB, Sarraf D et al. Sub RPE lipid: the Onion sign. Retina Society (Washington DC), 09/2012.

48. Chan C, Sarraf D et al. Analysis of Single Nucleotide Polymorphisms Profile for Eyes with Vascularized Pigment Epithelial Detachment due to AMD. Macula Society (Dana Point, CA), 02/2013.

49. Sarraf D, Rahimy E et al. Multilayered Pigment Epithelial Detachment: A New SD OCT Finding. Macula Society (Dana Point, CA), 02/2013.

50. Shah V, Freund KB, Sarraf D et al. Ultra-Widefield Fundus Autofluorescence Imaging in Central Serous Chorioretinopathy. Invest Ophthalmol Visual Sci. 54:2013.

51. Joseph A, Rahimy E, Freund KB, Sarraf D. Fundus Autofluorescence Findings and Ancillary Imaging in MEWDS Patients without White Dots. Invest Ophthalmol Visual Sci. 54:2013.

52. Rahimy E, Sarraf D, Fawzi A et al. Acute Macular Neuroretinopathy: New Insights into Pathogenesis and Association with Retinal Capillary Ischemia. Invest Ophthalmol Visual Sci. 54:2013.

53. Ciardella A, Pichi P, Cunningham E, Jumper MJ, Davis J, Albini T, Sarraf D, Bertelli E, Morara M, and Nucc P. Spectral domain-optical coherence tomography findings in acute syphilitic posterior placoid chorioretinopathy. Invest. Ophthalmol. Visual Sci. 54:2013

D. Sarraf, 07 2019, of 57

54. Chan C,Sarraf D, Abraham P, Nguyen D, Lin S, Lalezary M, Zhang K, and VPED Study GroupGenotype analysis for single nucleotide polymorphisms profile of eyes with vascularized pigment epithelial detachment due to AMD. Invest. Ophthalmol. Visual Sci. 54:2013.

55. Shah V, Sarraf D, and Freund KB. Ultra-widefield fundus autofluorescence imaging in central serous chorioretinopathy. Invest. Ophthalmol. Visual Sci. 54:2013

56. Sarraf D. Multimodal imaging of ASPPC. An international perspective. ASRS (Toronto, ON), 2013.

57. Sarraf D. Paracentral Acute Middle Maculopathy. Retina Society (Los Angeles, CA), 2013.

58. Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D. Mechanism of retinal pigment epithelium (RPE) tear formation revealed by spectral-domain optical coherence tomography (SD-OCT). Retina Society (Beverly Hills, CA) 2013.

59. Nagiel A, Freund KB, Sarraf D. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and response to therapy as revealed by spectral-domain optical coherence tomography. Invest Ophthalmol Visual Sci. 55, 2014.

60. Nagiel A, Freund KB, Spaide R, Querques G and Sarraf D. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and response to therapy as revealed by spectral-domain optical coherence tomography. Retina Society (Philadelphia PA), 2014.

61. Rahimy E, Sarraf D, Pitcher J, Ho Allen. Paracentral Acute Middle Maculopathy and CRVO. Retina Society (Philadelphia PA), 2014.

62. Sarraf D, Boeni C, Holland G Levinson R. and Jaffe G. Analysis of birdshot chorioretinopathy abnormalities using sd-oct and fundus autofluorescence imaging. Retina Society (Philadelphia PA), 2014.

63. Sarraf D, Rahimy E, Pitcher J, Ho A. SD-OCT Analysis of deep capillary plexus ischemia in central retinal vein occlusion. ASRS. San Diego, 2014.

64. Joseph A, Gelman S, Freund KB, Shah V, Sarraf D. The Pearl Necklace Sign: A novel spectral-domain optical coherence tomography finding in exudative macular disease. ASRS. San Diego, 2014.

65. Sarraf D et al. Visual and Anatomic Outcomes of Large PEDs Following Ranibizumab Therapy in Wet AMD Patients: Subgroup Analysis of the HARBOR Study. Macula Society (Scottsdale), 2015.

D. Sarraf, 07 2019, of 57

66. Chan C, Abraham P, Sarraf D et al. Prospective multimodal analysis of aflibercept treatment of pigment epithelial detachment in neovascular AMD: The Even Study. Invest Ophthalmol Vis Sci. 56, 2015.

67. Nagiel A, Sarraf D et al. Morphological Analysis of Type 1, Type 2, and Type 3 neovascularization in exudative age-related macular degeneration using OCT angiography. Invest Ophthalmol Vis Sci. 56, 2015.

68. Chen X, Rahimy E, Sergott RC, Nunes RP, Souza EC, Choudhry N, Cutler NE, Houston SK, Munk MR, Fwazi AA, Mehta S, Hubschman JP, Ho Allen, Sarraf D. Spectrum of retinal vascular diseases associated with Paracentral Acute Middle Maculopathy. Invest Ophthalmolo Vis Sci. 56, 2015.

69. Corvi F, Sarraf D et al. Long-term outcomes of anti-vascular endothelial growth factor treatment in diabetic patients with exudative age-related macular degeneration and concomitant diabetic retinopathy. Retina Society. Paris. 2015.

70. Pichi F, Sarraf D et al. En face and SSADA spectral domain OCT findings in MEWDS. AAO. Las Vegas NV. 2015 (November).

71. Chan C, Sarraf D et al. EVEN study: Prospective multimodal analysis of aflibercept for PED in neovascular AMD. AAO. Las Vegas NV. 2015 (November)

72. Sarraf d et al. Efficacy of ranibizumab therapy in eyes with neovascular AMD and pigment epithelial detachment (PED): a HARBOR subanalysis study. Invest Ophthalmolo Vis Sci. 56, 2016.

73. Tam A, Sarraf D et al. Alterations in the Choroid are Associated with Serous Macular Detachments in Myopic Patients with Staphyloma or Dome-shaped macula. Invest Ophthalmolo Vis Sci. 56, 2016.

74. Quequeres L, Bandello F, Corvi C, La Spina C, Benatti L, Sarraf D, Freund K, Battalgia Parodi M, Souied E.H, Quequeres G. Long-term outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy. ARVO. Seattle WA. May 2016.

75. Sarraf D, Hill L, Lu N, Gune S, Tuomi L. Efficacy of ranibizumab therapy in eyes with neovascular AMD and pigment epithelial detachment (PED): a HARBOR subanalysis study. ARVO. Seattle, WA. May 2016.

76. Inoue M, Jung J.J., Bala C, De Carlo T.E., Shahlee A, Klufas M.A., Duker J.S,. Ho A.C., Quaratana El-Maftouhi M, Sarraf D, Freund K. A cComparison of Optical Coherence Tomography Angiography to Fluorescein Angiography for the Imaging of Type 1 Neovascularization. ARVO. Seattle WA. May 2016.

77. Dansingani K K, Gilani F, Phasukkijwatana N, Novais E.A., Querques L, Sarraf D, Waheed N.K., Duker J.S., Querques G, Yannuzzi L, Freund K. Angiographic optical coherence tomography (OCT) of subretinal hyperreflective material (SHRM). ARVO. Seattle WA. May 2016.

D. Sarraf, 07 2019, of 57

78. Sarraf D. Imaging Choroidal Neovascularization with OCTA. ARVO. Seattle WA. May 2016.

79. Tan A C, Yzer S, Phasukkijwatana N, Dansingani K.K., Freund K, Sarraf D. Choroidal Changes Associated with Serous Macular Detachment in Eyes with Staphyloma or Dome-shaped Macula. ARVO. Seattle WA. May 2016.

80. Jung J J, Hoang Q.V, Rofagha S, Sarraf D, Freund K. Ultra-widefield Indocyanine Green Angiography in Central Serous Chorioretinopathy and Pachychoroid Pigment Epitheliopathy. ARVO. Seattle WA. May 2016.

81. Gilani F, Dansingani K.K., Gal-Or O, Phasukkijwatana N, Freund K, Sarraf D. Pachychoroid Findings Associated with Benign Choroidal Nevi. ARVO. Seattle WA 2016.

82. Nicholas A. Iafe, Nopasak Phasukkijwatana, Xuejing Chen, David Sarraf. Retinal Capillary Density and Foveal Avascular Zone Area are Age-Dependant: Quantitative Analysis using Optical Coherence Tomography Angiography. AAO Annual Meeting. Chicago IL 2016.

83. David Sarraf. Optical Coherence Tomography Angiography of Placoid Related Disorders. Retina Society. San Diego CA 2016.

84. Xuejing Chen, David Sarraf. Type 1 versus Type 3 Neovascularization in Pigment Epitheal Detachments (PEDs) Associated with Age-Related Macular Degeneration After Anti-VEGF Therapy in the EVEN Styudy: Post-hoc Analysis of a Prospective Study. Retina Society. San Diego CA 2016.

85. Anna Tan, David Sarraf. Choroidal Changes Associated with Serous Macular Detachment in Eyes with Staphyloma or Dome-shaped Macula. Retina Society. San Diego CA 2016.

86. Irena Tsui, David Sarraf. Abnormal Vessels in the Foveal Center in Premature Eyes: An Optical Coherence Angiography Study. Retina Society. San Diego CA 2016.

87. Michael Klufas, David Sarraf et al. OCT Angiography Reveals Choriocapillaris Ischemia in Placoid Chorioretinitis. AAO. Chicago Il 2016.

88. Nicholas A. Iafe, Nopasak Phasukkijwatana, Xuejing Chen, David Sarraf. Quantitative OCT Angiography of the Retinal Capillary System in Healthy Eyes According to Age. AAO. Chicago IL 2016.

89. David Xu, David Sarraf et al. Immature photoreceptor layer and inner retinal layers in full term neonates identified with optical coherence tomography. ARVO. Baltimore MD 2017.

D. Sarraf, 07 2019, of 57

90. David Sarraf. What are the Roles of Wide-angle and Other Advanced Retinal Imaging Technologies in the Management of Retinal Vascular Diseases? ARVO. Baltimore MD 2017.

91. Juan Pablo Davila, David Sarraf et al. OCT Angiography of Type 1 Neovascularization in AMD with Long-Term Follow Up Analysis. ARVO. Baltimore MD 2017.

92. Enrico Borrelli, David Sarraf et al. Choriocapillaris changes in intermediate age-related macular degeneration with and without fellow neovascular eyes. ARVO. Baltimore MD 2017.

93. Mayss Al-Sheikh, David Sarraf et al. Quantitative OCT Angiography of the Retinal Microvasculature and the Choriocapillaris in Myopic Eyes. ARVO. Baltimore MD 2017.

94. Giuseppe Querques, David Sarraf et al. Optical Coherence Tomography Angiography in Perifoveal Exudative Vascular Anomalous Complex. ARVO. Baltimore MD 2017.

95. Nopasak Phasukkijwatana, David Sarraf et al. Optical Coherence Tomography Angiography (OCTA) demonstrates enlarged foveal avascular zone and deceased macular vessel density in patients with migraine with aura. ARVO. Baltimore MD 2017.

96. Ananda Kalevar, David Sarraf et al. En Face OCT Analysis to Assess the Spectrum of Perivenular Ischemia and PAMM in Retinal Vascular Occlusion. ARVO. Baltimore MD 2017.

97. Marcela Lonngi, David Sarraf et al. Spectral Domain Optical Coherence Tomography Angiography in Children with Amblyopia. ARVO. Baltimore MD 2017.

98. Sean T. Garrity, David Sarraf et al. Quantitative Analysis of Retinal Capillary Density and Foveal Avascular Zone Area Using Optical Coherence Tomography Angiography of Normal Eyes. ARVO. Baltimore MD 2017.

99. Nicholas Iafe, David Sarraf et al. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density after Anti-VEGF Therapy in Eyes with Diabetic Macular Edema and Retinal Vein Occlusion. ARVO. Baltimore MD 2017.

100. Nopasak Phasukkijwatana, David Sarraf et al. Peripapillary Pachychoroid Syndrome. ARVO. Baltimore MD 2017.

101. Andrea Govetto, David Sarraf et al. Insights Into Epiretinal Membranes Evolution: Presence Of Continuous Ectopic Inner Foveal Layers And A New Optical Coherence Tomography Staging Scheme. ARVO. Baltimore MD 2017.

D. Sarraf, 07 2019, of 57

102. David Sarraf. Quantitative OCT Angiography of the Retina Microvasculature and the Choriocapillaris in Myopic Eyes. ARVO Annual Meeting 2017. Baltimore MD 2017.

103. Sarraf D et al. En Face OCT and OCT Angiography to Assess the Spectrum of Perivenular Ischemia and PAMM in Retinal Vascular Occlusion. American Ophthalmological Society. Hot Springs VA. May 2017.

104. Sarraf D et al. En Face OCT and OCT Angiography to Assess the Spectrum of Perivenular Ischemia and PAMM in Retinal Vascular Occlusion. ASRS. Boston MA. August 2017.

105. Garrity S, Sarraf D, et al. Quantitative Analysis of Retinal Capillary Density and Foveal Avascular Zone Area Using Optical Coherence Tomography Angiography of Normal Eyes. Retina Society. Boston MA. September 2017.

106. Sarraf D et al. OCT Angiography To Assess Flow Deficit Of The Choroid In Myopia. Retina Society. Boston MA. October 2017.

107. Corradetti G, Pichi D, Sarraf D et al. The Association Of Venous Malformations Of The Retina And Brain. ARVO. Honolulu HI 05 2018.

108. Leong B, Freund KB, Sarraf D et al. OCT Angiography Of Collaterals In Branch Retinal Vein Occlusion Supports In Series Arrangement Of Retinal Flow With Origin Of Venous Outflow In Deep Vascular Complex. ARVO Honolulu HI 05 2018.

109. Balasubramanian S, Sarraf D et al. Visual Function And OCT Angiography Features In Children Born Preterm. ARVO Honolulu HI 05 2018.

110. Xu D, Sarraf D et al. OCT Angiography of Long-Term Progression of Type 1 Neovascularization in Age Related Macular Degeneration. ARVO Honolulu HI 05 2018.

111. Garg E, Sarraf D et al. Acquired Vitelliform Maculopathy in Pachychoroid Pigment Epitheliopathy and Comparison to Acquired Vitelliform Maculopathy in Reticular Drusen. ARVO Honolulu HI 05 2018.

112. Bakhoum M, Sarraf D et al. Endothelial Corneal Dystrophy is Penetrant in Mitochondrial Disorders. ARVO Honolulu HI 2018

113. Sarraf D, Govetto A et al. OCT And Histopathological Analysis of the Tractional Abnormalities of the Central Foveal Bouquet Associated with Epiretinal Membrane Formation. ARVO Honolulu HI 2018

114. Hou K, Sarraf D et al. Evaluation of Pseudoflow Artifact with OCT Angiography. ARVO Honolulu HI 05 2018

D. Sarraf, 07 2019, of 57

115. Garrity S, Sarraf D et al. Spectral domain OCT abnormalities preceding visual field changes in hydroxychloroquine retinopathy. ARVO Honolulu HI 05 2018

116. Fan W, Sarraf D et al. Choriocapillaris Flow Signal Void on OCT Angiography in Myopic Eyes. ARVO Honolulu HI 05 2018

117. Ali MH, Sarraf D et al. Quantitative Assessment of Normal Iris Vascular Density using Anterior Segment OCT Angiography. ARVO Honolulu HI 05 2018

118. Tsui I, Sarraf D, et al. Retinal Vascular Changes During Pregnancy Using Ocular Coherence Tomography Angiography Evaluation, Retina Society, San Francisco CA, 09 2018

119. S Sadda, Sarraf D, et al. Topographical Analysis of the Choriocapillaris in Intermediate Age-related Macular Degeneration. Retina Society, San Francisco CA, 09 2018

120. Sarraf D et al, Cilioretinal artery insufficiency and its association with middle retinal layer ischemia and paracentral acute middle maculopathy (PAMM). Retina Society, San Francisco CA, 09 2018

121. Sarraf D et al. 3D Volumetric Analysis of Vascularized Serous PED Progression in Neovascular AMD. ARVO Vancouver Canada 04 2019

122. Gunzenhauser R, Sarraf D et al. Comparison of Structural and Visual Outcomes in Laser-Treated versus Untreated Eyes with ROP. ARVO Vancouver Canada 04 2019

123. Iovino C, Sarraf D et al. Evaluation of Choroidal Characteristics and their Association with CME in Patients with RP. ARVO Vancouver Canada 04 2019

124. Xu X, Sarraf D et al. Differentiating Veins from Arteries on OCTA using Vortices in the Deep Capillary Plexus to Identify Venous Outflow Origin. ARVO Vancouver Canada 04 2019

125. Lenis TL, Sarraf D et al. Foveal Central Bouquet Abnormalities in Early CME from CRVO, Irvine-Gass Syndrome, and Uveitis. ARVO Vancouver Canada 04 2019

126. Falavarjani K, Sarraf D et al. Effect of Segmentation Error Correction on OCTA Measurements in Healthy Subjects and DME. ARVO Vancouver Canada 04 2019

127. Long CO, Bakhoum M, Sarraf D et al. Dilation of the Retinal Capillary Plexuses

in BRVO. ARVO Vancouver Canada 04 2019

128. Jung JY, Sarraf D et al. Co-Localization of Hyperautofluorescent Ring and Ellipsoid Zone Area in Patients with RP using En Face OCT. ARVO Vancouver Canada 04 2019

D. Sarraf, 07 2019, of 57

Peer-Reviewed Research Papers

1. Pruzanski W, Sarraf D, Klein M, Lau CY, Richardson JE. Lymphocytotoxic antibodies in vasculitis. J Rheumatol 13:1066-71, 1986.

2. Sarraf D, Lee DA. Iontophoresis of Reactive Black 5 for pulsed dye laser sclerostomy. J Ocular Pharmacol 9:25-33, 1993.

3. Sarraf D, Equi RA, Holland GN, Yoshizumi M, Lee DA. Transscleral iontophoresis of Foscarnet. Amer J Ophthalmol 115:748-54, 1993.

4. Sarraf D, Eezzuduemhoi RD, Cheng Qi, Wilson MR, Lee DA. Aqueous and vitreous concentration of Mitomycin C by topical administration after glaucoma filtration surgery in rabbits. Ophthalmol 100:1574-9, 1993.

5. Grossman RE, Sarraf D, Lee DA. Iontophoresis of Methylene Blue for pulsed dye laser sclerostomy. J Ocular Pharmacol 9:277-85, 1993.

6. Goldberger S, Sarraf D, Bernstein JM, Hurwitz JJ. Involvement of the eyebrow fat pad in Graves' orbitopathy. Ophthalmic Plastic Reconst Surg 10:80-6, 1994.

7. Yoshizumi MO, Lee DA, Sarraf D, Equi RA, Verdon W. Transscleral iontophoresis of Foscarnet: a toxicity study. J Ocular Pharmacol 11:183-9, 1995.

8. Sarraf D, Gin T, Yu F, Brannon A, Owens SL, Bird AC. Long-term drusen study. Retina 19:513-19, 1999.

9. Sarraf D, Payne A, Kitchen N, Sehmi K, Downes S, Bird AC. Familial cavernous hemangioma: an expanding ocular spectrum. Arch Ophthalmol 118: 969-73, 2000.

10. Read RW, Holland GN, Rao NA et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647-52, 2001.

11. Sarraf D, Ceron O, Rasheed K, Drenser K, Casey R. West African Crystalline Maculopathy. Arch Ophthalmol 121:338-42, 2003.

12. Sarraf D, Schwartz SD. Bilateral choroidal folds and optic neuropathy: a variant of the crowded disk syndrome? Ophthalmol 110:1047-52, 2003.

13. Quiram P, Dumars S, Sarraf D. Viagra-associated serous macular detachment. Graefes Arch Clin Exp Ophthalmol 243:339-44, 2005.

14. Szabo SM, Schmidt-Erfurth U, Sarraf D, Michels R, Potter MJ. Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis. Can J Ophthalmol 41:34-37, 2006.

15. Bourla D, Sarraf D, Schwartz SD. Peripheral retinopathy and maculopathy

D. Sarraf, 07 2019, of 57

associated with high dose Tamoxifen therapy. Amer J Ophthalmol 144: 126-8, 2007.

16. Chang L, Sarraf D. Tears of the RPE: an old problem in a new era. Retina 27:523-34, 2007.

17. Sarraf D, Salib D, Jain A. The coexistence of age-related macular degeneration and retinitis pigmentosa in threee unrelated families .Sem Ophthalmol 22:155-61, 2007.

18. Chang L, Flaxel C, Lauer A, Sarraf D. RPE tears after pegaptanib treatment in ARMD. Retina 27:857-63, 2007.

19. Nusinowitz S, Sarraf D. Retinal function in X-Linked Ocular Albinism (OA-1). Current Eye Research 33:789-803, 2008.

20. Chiang A, Chang LK, Yu F, and Sarraf D. Predictors of anti-VEGF-associated RPE tears using FA and OCT analysis. Retina 28:1265-9, 2008.

21. Chen JL, Luviano DM, Chen JC, Yu F, Sarraf D. Comparison of diabetic retinopathy phenotype between Latinos and Blacks. J Diabetes Complications 23:371-5, 2009.

22. Kaines A, Tsui I, Sarraf D, Schwartz S. The use of ultra wide field fluorescein angiography in evaluation and management of uveitis. Semin Ophthalmol. 24:19-24, 2009.

23. Jain A, Desai RU, Charalel RA, Quiram P, Yannuzzi L, Sarraf D. Solar Retinopathy: Comparison of Optical Coherence Tomography (OCT) and Fluorescein Angiography (FA). Retina 29:1340-5, 2009.

24. Sarraf D, Reddy S, Chiang A, Yu F, Jain A. A new classification system for RPE tears. Retina 30:1039-45. 2010.

25. Sarraf D, Vyas N, Jain A, Bui A, Kertes P, Freund KB, Chan C. Triamcinolone associated crystalline maculopathy. Archives of Ophthalmology 128:685-90, 2010.

26. Yuan A, Kaines A, Reddy S, Jain A, Schwartz SD, Sarraf D. Ultra wide field and autofluorescence imaging of choroidal dystrophies. Ophthalmic Surgery, Lasers, Imaging 28:41, 2010.

27. Choi DY, Ortube MC, Mccannel CA, Sarraf D, Hubschman JP, Mccannel TA, Gorin MB. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.Retina 31:1028-35, 2011.

28. Chan CK, Abraham P, Sarraf D. High-dose ranibizumab therapy for vascularized pigment epithelial detachment. Eye 26:882-5, 2012.

29. Fawzi AA, Pappuru RR, Sarraf D, Le PP, McCannel CA, Sobrin L, Goldstein

D. Sarraf, 07 2019, of 57

http://journals.lww.com/retinajournal/Abstract/2011/06000/Sustained_Elevated_Intraocular_Pressures_After.3.aspx

http://journals.lww.com/retinajournal/Abstract/2011/06000/Sustained_Elevated_Intraocular_Pressures_After.3.aspx

DA, Honowitz S, Walsh AC, Sadda SR, Jampol LM, Eliott D. Acute Macular Neuroretinopathy. Long-term insights as revealed by multimodal imaging. Retina 32:1500-13, 2012.

30. Mukkamala SK, Costa RA, Fung A, Sarraf D, Gallego-Pinazo R, Freund KB. OCT Imaging of Sub RPE Lipid. Arch Ophthalmol. 13:1-7, 2012.

31. Goldman D, Freund KB, McCannel CA, Sarraf D. Peripheral Polypoidal Choroidal Vasculopathy as a Cause of Peripheral Exudative Hemorrhagic Chorioretinopathy: A Report of Ten Eyes. Retina 33:48-55, 2013.

32. Gabrielian A, Maccumber MM, Kukuyev A, Mitsuyasu R, Holland GN, Sarraf D. DDI-associated retinal toxicity in adults with human immunodeficiency virus. JAMA Ophthalmol. 131:255-9, 2013.

33. Sarraf D, Chan C, Rahimy E, Abraham P. Prospective evaluation of the incidence and risk factors for the development of RPE Tears after high- and low-dose ranibizumab therapy. Retina. 33:1551-7, 2013.

34. Varshney N, Jain A, Chan V, Yu L, Sarraf D. Anti-VEGF response in macular hemorrhage and incidence of retinal pigment epithelial tears. Can J Ophthalmol. 48:210-5, 2013.

35. Sarraf D, Rahimy E, Fawzi AA, Sohn E, Barbazetto I, Zacks DN, Mittra RA, Klancnik JM, Mrejen S, Goldberg NR, Beardsley R, Sorenson JA, Freund KB. Paracentral Acute Middle Maculopathy: A new variant of acute macular neuroretinopathy associated with retinal capillary ischemia. JAMA Ophthalmol. 131:1275-87, 2013.

36. Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Am J Ophthalmol. 156:981-88, 2013.

37. Joseph A, Rahimy E, Freund KB, Sorenson JA, Sarraf D. Fundus autofluorescence and photoreceptor bleaching in multiple evanescent white dot syndrome. Ophthalmic Surg Lasers Imaging Retina. 44(6):588-92, 2013.

38. Rahimy E, Beardsley RM, Gomez J, Hung C, Sarraf D. Grading of posterior staphyloma with spectral-domain optical coherence tomography and correlation with macular disease. Can J Ophthalmol. 48:539-45, 2013.

39. Pichi F, Ciardella AP, Cunningham ET Jr, Morara M, Veronese C, Jumper JM, Albini TA, Sarraf D, Neri P, Nucci P. Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy. Retina. 34:373-84, 2014.

40. Rahimy E, Freund KB, Larsen M, Spaide RF, Costa RA, Hoang Q, Christakopoulos C, Munch IC, Sarraf D. Multilayered pigment epithelial

D. Sarraf, 07 2019, of 57

detachment in neovascular age-related macular degeneration. Retina. 34:1289-95, 2014.

41. Pang CE, Shah VP, Sarraf D, Freund KB. Ultra-Widefield Imaging with Autofluorescence and indocyanine green angiography in central serous chorioretinopathy. Am J Ophthalmol. 158:362-71, 2014.

42. Rahimy E, Sarraf D, Dollin ML, Pitcher JD, Ho AC. Paracentral Acute Middle Maculopathy in nonischemic central retinal vein occlusion. Am J Ophthalmol. 158:372-80, 2014.

43. Gelman S, Freund KB, Shah V, Sarraf D. The Pearl Necklace Sign: A novel spectral-domain optical coherence tomography finding in exudative macular disease. Retina. 34:2088-95, 2014.

44. Chan C, Abraham P, Sarraf D et al. Earlier therapeutic effects associated with high-dose (2.0 Mg) ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration. Eye. 10:1038, 2014.

45. Kozak I, Mansour A, Diaz RI, Calzada JI, Pichi F, Cruz-Villegas V, Diaz-Llopis M, Gallego-Pinazo R, Chhablani J, Martinez-Cartier M, Meerhoff M, Mieler WF, Arevalo JF, King Khaled Eye Specialist Hospital International Collaborative Retina Study Group (Sarraf D). Retina. 34:2044-52, 2014.

46. Pang CE, Sarraf D, Freund KB. Extreme choroidal thinning in high myopia. Retina. 35:407-15, 2014.

47. Kim HY, Hodapp E, Grajewski AL, Sarraf D, et al. Peripheral retinal vasculopathy in childhood glaucoma. Retina 35(5):1028-35, 2014.

48. Mrejen S, Pang CE, Sarraf D, Goldberg NR, Gallego-Pinazo R, Klancnik JM, Sorenson JA, Yannuzzi LA, Freund KB. Adaptive optics imaging of cone mosaic abnormalities in acute macular neuroretinopathy. Ophthalmic Surg Lasers Imaging Retina. 45(6):562-9, 2014.

49. Sarraf D, Joseph A, Rahimy E. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis). Transactions of the American Ophthalmological Society. 112:142-59, 2014.

50. Yu S, Pang CE, Gong Y, Freund KB, Yannuzzi LA, Rahimy E, Lujan BJ, Tabandeh H, Cooney MJ, Sarraf D. The spectrum of superficial and deep capillary ischemia in retinal artery occlusion. American J Ophthalmol. 159(1):53-63, 2015.

51. Nagiel A, Sarraf D, Sadda SR, Spaide RF, Jung JJ, Bhavsar KV, Ameri H, Querques G, Freund KB. Type 3 neovascularization: Evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina 35(4):638-47, 2015.

D. Sarraf, 07 2019, of 57

52. Chen X, Rahimy E, Sarraf D et al. Spectrum of retinal vascular disease associated with PAMM. American J Ophthalmol. 160(1):26-34, 2015.

53. Kuehlewein L, Bansal M, Lenis TL, Iafe NA, Sadda SR, Bonini Filho MA, De Carlo TE, Waheed NK Duker JS, Sarraf D. Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration. Am J Ophthalmol. 160(4);739-48, 2015.

54. Munk MR, Jampol LM, Cunha Souza E, de Andrade GC, Esmaili DD, Sarraf D, Fawzi AA. New associations of classic acute macular neuroretinopathy. Br J Ophthalmol. 100(3):389-94, 2015.

55. Roybal CN, Sanfilippo CJ, Nazari H, Law JC, Bhaleeya S, Chui Ming GC, Rao NA, Kiss S, Agarwal A, Sadda S, Sarraf D. Multimodal imaging of the retina and choroid in systemic amyloidosis. Retinal Cases Brief Reports. 9(4):339-46, 2015.

56. Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol. 160(6);1243-54; 2015.

57. Nemiroff J, Kuehlewein L, Rahimy E, Tsui I, Doshi R, Gaudric A, Gorin MB, Sadda S, Sarraf D. Assessing deep retinal capillary ischemia in paracentral acute middle maculopathy by Optical Coherence Tomography Angiography. Am J Ophthalmol. 162:121-32, 2015.

58. Kuehlewein L, Dansingani KK, de Carlo TE, Bonini Filho MA, Iafe NA, Lenis TL, Freund KB, Waheed NK, Duker JS, Sadda SR, Sarraf D. Optical coherence tomography angiography of type 3 neovascularization secondary to age-related macular degeneration. Retina 35(11): 2229-35, 2015.

59. Bonini Filho MA, Adhi M, de Carlo TE, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Kuehlewein L, Sadda SR, Sarraf D, Duker JS, Waheed NK. Optical coherence tomography angiography in retinal artery occlusion. Retina. 35(11):2339-46, 2015.

60. Mrejen S, Sarraf D, Chexal S, Wald K, Freund KB. Choroidal Involvement in Acute Posterior Multifocal Placoid Pigment Epitheliopathy. Ophthalmic Surg Lasers Imaging Retina. 47:20-6, 2016.

61. Bandello F, Corvi F, La Spina C, Benatti L, Querques L, Capuano V, Naysan J, Chen X, Sarraf D, Parodi MB, Souied E, Freund KB, Querques G. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy. Br J Ophthalmol. 2016.

62. Balaratnasingam C, Freund KB, Tan AM, Mrejen S, Hunyor AP, Keegan DJ, Dansingani KK, Dayani PN, Barbazetto IA, Sarraf D, Jampol LM, Yannuzzi LA. Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging. Ophthalmology. 2016.

D. Sarraf, 07 2019, of 57

63. Dansingani KK, Tan A, Gilani F, Phasukkijwatana N, Novais E, Querques L, Waheed NK, Duker JS, Querques G, Yannuzzi LA, Sarraf D, Freund KB. Subretinal Hyperreflective Material Imaged with Optical Coherence Tomography Angiography. Am J Ophthalmol. 2016.

64. Inoue M, Jung JJ, Balaratnasingam C, Dansingani KK, Dhrami-Gavazi E, Suzuki M, de Carlo TE, Shahlaee A, Klufas MA, El Maftouhi A, Duker JS, Ho AC, Maftouhi MQ, Sarraf D, Freund For The Coft-1 Study Group KB. AComparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization. Invest Ophthalmol Vis Sci. 2016.

65. Dolz-Marco R, Phasukkijwatana N, Sarraf D, Freund KB. Optical Coherence Tomography Angiography in Fovea Plana. Ophthalmic Surg Lasers Imaging Retina. 2016.

66. Adhi M, Filho MA, Louzada RN, Kuehlewein L, de Carlo TE, Baumal CR, Witkin AJ, Sadda SR, Sarraf D, Reichel E, Duker JS, Waheed NK. Retinal Capillary Network and Foveal Avascular Zone in Eyes with Vein Occlusion and Fellow Eyes Analyzed with Optical Coherence Tomogrphy Angiography. Invest Ophthalmol Vis Sci. 2016.

67. Ghasemi Falavarjani K, Scott AW, Wang K, Han IC, Chen X, Klufas M, Hubschman JP, Schwartz SD, Sadda SR, Sarraf D, Tsui I. Correlation of Multimodal Imaging in Sickle Cell Retinopathy. Retina. 2016.

68. Phasukkijwatana N, Tan AC, Chen X, Freund KB, Sarraf D. Optical Coherence Tomography Angiography of Type 3 Neovascularization in Age-Related Macular Degeneration After Antiangiogenic Therapy. Br J Ophthalmol. 2016.

69. Sarraf D, London NJ, Khurana RN, Dugel PU, Gune S, Hill L, Tuomi L. Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study. Ophthalmology. 2016.

70. Su D, Lin S, Phasukkijwatana N, Chen X, Tan A, Freund KB, Sarraf D. An Updated Staging System of Type 3 Neovascularization Using Spectral Domain Optical Coherence Tomography. Retina. 2016

71. Govetto A, Sarraf D, Figueroa MS, Pierro L, Ippolito M, Risser G, Bandello F, Hubschman JP. Choroidal Thickness in Non-Neovascular versus Neovascular Age-Related Macular Degeneration: a Fellow Eye Comparative Study. Br J Ophthalmol. 2016.

72. Boni C, Thorne JE, Spaide RF, Ostheimer TA, Sarraf D, Levinson RD, Goldstein DA, Rifkin LM, Vitale At, Jaffe GJ, Holland GN. Choroidal Findings in Eyes with Birdshot Chorioretinitis Using Enhanced-Depth Optical Coherence Tomography. Invest Ophthalmol Vis SCi. 2016.

D. Sarraf, 07 2019, of 57

73. Chen X, Al-Sheikh M, Chan CK, Hariri AH, Abraham P, Lalezary M, Lin SG, Sadda S, Sarraf D. Type 1 Versus Type 3 Neovascularization in Pigment Epithelial Detachments Associated with Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Therapy: A Prospective Study. Retina. 2016.

74. Dolz-Marco R, Phasukkijwatana N, Sarraf D, Freund KB. Regression of Type 2 Neovascularization into a Type 1 Pattern After Intrvitreal Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. Retina. 2016.

75. Haug SJ, Wong RW, Day S, Choudry N, Sneed S, Prasad P, Read S, McDonald RH, Agarwal A, Davis J, Sarraf D. Didanosine Retinal Toxicity. Retina. 2016.

76. Tan AC, Dansingani KK, Yannuzzi LA, Sarraf D, Freund KB. Type 3 Neovascularization Imaged with Cross- Sectional and En Face Optical Coherence Tomography Angiography. Retina. 2016

77. Mouallem A, Sarraf D, Chen X, Capuano V, Souied EH, Querques G. Double Retinal Pigment Epithelium Tears in Neovascular Age-Related Macular Degeneration. Retina. 2016.

78. Iafe NA, Phasukkijwatana N, Chen X, Sarraf D. Retinal Capillary Density and Foveal Avascular Zone Area Age- Dependent: Quantitative Analysis Using Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2016.

79. Klufas MA, Phasukkijwatana N, Iafe NA, Prasad PS, Agarwal A, Gupta V, Ansari A, Pichi F, Srivastava S, Freund KB, Sadda SR, Sarraf D. Optical Coherence Tomography Angiography Reveals Choriocapillaris Flow Reduction in Placoid Chorioretinitis. Ophthalmology Retina. 2016.

80. Tan AC, Yzer S, Freund KB, Dansingani KK, Phasukkijwatana N, Sarraf D. Choroidal Changes Associated with Serous Macular Detachment in Eyes with Staphyloma, Dome-Shaped Macula or Tilted Disk Syndrome. Retina. 2016.

81. Pichi F, Srvivastava SK, Chexal S, Lembo A, Lima LH, Neri P, Saitta A, Chhablani J, Albini TA, Nucci P, Freund KB, Chung H, Lowder CY, Sarraf D. En Face Optical Coherence Tomography And Optical Coherence Tomography Angiography Of Multiple Evanescent White Dot Syndrome: New Insights Into Pathogenesis. Retina. 2016.

82. Falavarjani KG, Iafe NA, Velez FG, Schwartz SD, Sadda SR, Sarraf D, Tsui I. Optical coherence tomography angiography of the fovea in children born preterm. Retina. 2017.

83. Holz FG, Sadda SR, Staurenghi G, Lindner M, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Curcio CA, Danis R, Fleckenstein M, Freund KB, Grunwald J, Guymer R, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Oishi A,

D. Sarraf, 07 2019, of 57

https://www.ncbi.nlm.nih.gov/pubmed/28098735




Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Schmitz-Valckenberg S; CAM group. Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. Ophthalmology. 2017.

84. Ghasemi Falavarjani K, Iafe NA, Hubschman JP, Tsui I, Sadda SR, Sarraf D. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion. Invest Ophthalmol Vis Sci. 2017.

85. Al-Sheikh M, Phasukkijwatana N, Dolz-Marco R, Rahimi M, Iafe NA, Freund KB, Sadda SR, Sarraf D. Quantitative OCT Angiography of the Retinal Microvasculature and the Choriocapillaris in Myopic Eyes. Invest Ophthalmol Vis Sci. 2017.

86. Govetto A, Lalane RA 3rd, Sarraf D, Hubschman JP, Figueroa MS. Insights Into Epiretinal Membranes: Presence of Ectopic Inner Foveal Layers and a New Optical Coherence Tomography Staging Scheme. Am J Ophthalmol. 2017.

87. Giannakaki-Zimmermann H, Querques G, Munch IC, Shroff D, Sarraf D, Chen X, Cunha-Souza E, Mrejen S, Capuano V, Rodrigues MW, Gupta C, Ebneter A, Zinkernagel MS, Munk MR. Atypical retinal pigment epithelial defects with retained photoreceptor layers: a so far disregarded finding in age related macular degeneration. BMC Ophthalmol. 2017.

88. Al-Sheikh M, Iafe NA, Phasukkijwatana N, Sadda SR, Sarraf D. Biomarkers Of Neovascular Activity In Age-Related Macular Degeneration Using Oct Angiography. Retina. 2017.

89. Christenbury JG, Phasukkijwatana N, Gilani F, Freund KB, Sadda S, Sarraf D. Progression Of Macular Atrophy In Eyes With Type 1 Neovascularization And Age-Related Macular Degeneration Receiving Long-Term Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: An Optical Coherence Tomographic Angiography Analysis. Retina. 2017.

90. Böni C, Thorne JE, Spaide RF, Ostheimer TA, Sarraf D, Levinson RD, Goldstein DA, Rifkin LM, Vitale AT, Jaffe GJ, Holland GN. Fundus Autofluorescence Findings in Eyes With Birdshot Chorioretinitis. Invest Ophthalmol Vis Sci. 2017.

91. Falavarjani KG, Freund KB, Sadda S, Sarraf D. En Face Optical Coherence Tomography Analysis to Assess the Spectrum of Perivenular Ischemia and Paracentral Acute Middle Maculopathy in Retinal Vein Occlusion. Am J Ophthalmol. 2017.

92. Preti RC, Govetto A, Filho RGA, Cabral Zacharias L, Gianotti Pimentel S, Takahashi WY, Monteiro MLR, Hubschman JP, Sarraf D. Optical Coherence Tomography Analysis Of Outer Retinal Tubulations: Sequential Evolution And Pathophysiological Insights. Retina. 2017.

D. Sarraf, 07 2019, of 57







93. Lonngi M, Velez FG, Tsui I, Davila JP, Rahimi M, Chan C, Sarraf D, Demer JL, Pineles SL. Spectral-Domain OCT Angiography in Children With Amblyopia. JAMA Ophthalmology 135(10):1086-1091, 2017.

94. Borrelli E, Uji A, Sarraf D, Sadda SR. Alterations in the Choriocapillaris in Intermediate Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 58(11): 4792-4798 2017.

95. Chang MY, Phasukkijwatana N, Garrity S, Pineles SL, Rahimi M, Sarraf D, Johnston M, Charles A, Arnold AC. Foveal and Peripapillary Vascular Decrement in Migraine With Aura Demonstrated by Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2017.

96. Garrity ST, Iafe NA, Phasukkijwatana N, Chen X, Sarraf D. Quantitative Analysis of Three Distinct Retinal Capillary Plexuses in Healthy Eyes Using Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2017.

97. Sacconi R, Freund KB, Yannuzzi LA, Dolz-Marco R, Souied E, Capuano V, Semoun O, Phasukkijwatana N, Sarraf D, Carnevali A, Querques L, Bandello F, Querques G. The Expanded Spectrum of Perifoveal Exudative Vascular Anomalous Complex. Am J Ophthalmol. 2017.

98. Sadda SR, Sarraf D et al. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology. 2017.

99. Govetto A, Bhavsar KV, Virgili G, Gerber MJ, Freund KB, Curcio CA, Burgoyne CF, Hubschman JP, Sarraf D. Tractional Abnormalities of the Central Foveal Bouquet in Epiretinal Membranes: Clinical Spectrum and Pathophysiological Perspective. Am J Ophthalmol. 2017.

100. Phasukkijwatana N, Freund KB, Dolz-Marco R, Al-Sheikh M, Keane PA, Egan CA, Randhawa S, Stewart JM, Liu Q, Hunyor AP, Kreiger A, Nagiel A, Lalane R, Rahimi M, Lee WK, Jampol LM, Sarraf D. Peripapillary Pachychoroid Syndrome. Retina. 2017.

101. Govetto A, Virgili G, Rodriguez FJ, Figueroa MS, Sarraf D, Hubschman JP. Functional And Anatomical Significance Of The Ectopic Inner Foveal Layers In Eyes With Idiopathic Epiretinal Membranes: Surgical Results At 12 Months. Retina. 2017.

102. Xu David, Sarraf David et al. Long-term Progression of Type 1 Neovascularization in Age-related Macular Degeneration Using Optical Coherence Tomography Angiography. Am J Ophthalmol. 2017

103. Kashani A, Sarraf d et al. Suspended Scattering Particles in Motion: A Novel Feature of OCT Angiography in Exudative Maculopathies. Ophthalmology Retina 2017.

D. Sarraf, 07 2019, of 57


104. Falavarjani KG, Sarraf D, Tsui I. Optical Coherence Tomography Angiography of the Macula in Adults With a History of Preterm Birth. Ophthalmic Surg Lasers Imaging Retina. 49:122-125. 2018.

105. Bakhoum MF, Wu WP, White EC, Sengillo JD, Sanfilippo C, Morcos MM, Freund KB, Perry HD, Sarraf D, Tsang SH. Mitochondrial A3243G mutation results in corneal endothelial polymegathism. Graefes Arch Clin Exp Ophthalmol. 2018

106. Borrelli E, Lonngi M, Balasubramanian S, Tepelus TC, Baghdasaryan E, Iafe NA, Pineles SL, Velez FG, Sarraf D, Sadda SR, Tsui I. Macular Microvascular Networks In Healthy Pediatric Subjects. Retina. 2018

107. Pichi F, Freund KB, Ciardella A, Morara M, Abboud EB, Ghazi N, Dackiw C, Choudhry N, Souza EC, Cunha LP, Arevalo JF, Liu TYA, Wenick A, He L, Villarreal G Jr, Neri P, Sarraf D. Congenital Retinal Macrovessel and the Association of Retinal Venous Malformations With Venous Malformations of the Brain. JAMA Ophthalmol. 2018

108. Chae B, Su D, Gal-Or O, Freund KB, Sarraf D. Type 3 neovascularisation: long-term analysis of visual acuity and optical coherence tomography anatomical outcomes. Br J Ophthalmol. 2018

109. Chan CK, Sarraf D, Abraham P. Treatment outcomes of conventional or high-dose ranibizumab for vascularized pigment epithelial detachment based on lesion subtypes. Eur J Ophthalmol. 2018

110. Borrelli E, Souied EH, Freund KB, Querques G, Miere A, Gal-Or O, Sacconi R, Sadda SR, Sarraf Reduced Choriocapillaris Flow In Eyes With Type 3 Neovascularization And Age-Related Macular Degeneration. Retina. 2018

111. Velez FG, Davila JP, Diaz A, Corradetti G, Sarraf D, Pineles SL. Association of Change in Iris Vessel Density in Optical Coherence Tomography Angiography With Anterior Segment Ischemia After Strabismus Surgery. JAMA Ophthalmol. 136(9):1041-1045. 2018

112. Borrelli E, Lonngi M, Balasubramanian S, Tepelus TC, Baghdasaryan E, Pineles SL, Velez FG, Sarraf D, Sadda SR, Tsui I. Increased choriocapillaris vessel density in amblyopic children: a case-control study. J AAPOS. 22(5):366-370. 2018

113. Au A, Hou K, Baumal CR, Sarraf D. Radial Hemorrhage in Henle Layer in Macular Telangiectasia Type 2. JAMA Ophthalmol. 136(10):1182-1185. 2018

114. Bakhoum MF, Freund KB, Dolz-Marco R, Leong BCS, Baumal CR, Duker JS, Sarraf D.Paracentral Acute Middle Maculopathy and the Ischemic Cascade Associated With Retinal Vascular Occlusion. Am J Ophthalmol. 195:143-153. 2018

D. Sarraf, 07 2019, of 57

115. Borrelli E, Shi Y, Uji A, Balasubramanian S, Nassisi M, Sarraf D, Sadda SR. Topographic Analysis of the Choriocapillaris in Intermediate Age-related Macular Degeneration. Am J Ophthalmol. 196:34-43. 2018

116. Balasubramanian S, Borrelli E, Lonngi M, Velez F, Sarraf D, Sadda SR, Tsui I. Visual Function And Optical Coherence Tomography Angiography Features In Children Born Preterm. Retina. 2018

117. Pichi F, Fragiotta S, Freund KB, Au A, Lembo A, Nucci P, Sebastiani S, Gutierrez Hernandez JC, Interlandi E, Pellegrini F, Dolz-Marco R, Gallego-Pinazo R, Orellana-Rios J, Adatia FA, Munro M, Abboud EB, Ghazi N, Cunha Souza E, Amer R, Neri P, Sarraf D. Cilioretinal artery hypoperfusion and its association with paracentral acute middle maculopathy. Br J Ophthalmol. 2018

118. Freund KB, Sarraf D, Leong BCS, Garrity ST, Vupparaboina KK, Dansingani KK. Association of Optical Coherence Tomography Angiography of Collaterals in Retinal Vein Occlusion With Major Venous Outflow Through the Deep Vascular Complex. JAMA Ophthalmol. 136(11):1262-1270. 2018

119. Navajas EV, Schuck N, Govetto A, Akil H, Docherty G, Heisler M, Sarunic MV, Sarraf D. En Face Optical Coherence Tomography And Optical Coherence Tomography Angiography Of Inner Retinal Dimples After Internal Limiting Membrane Peeling For Full-Thickness Macular Holes. Retina. 2019

120. Garrity ST, Jung JY, Zambrowski O, Pichi F, Su D, Arya M, Waheed NK, Duker JS, Chetrit Y, Miserocchi E, Giuffrè C, Kaden TR, Querques G, Souied EH, Freund KB, Sarraf D. Early Hydroxychloroquine Retinopathy: Optical Coherence Tomography Abnormalities Preceding Humphrey Visual Field Defects.Br J Ophthalmol. 2019

121. Corbelli E, Parravano M, Sacconi R, Sarraf D, Yu SY, Kim K, Capuano V, Miere A, Souied E, Varano M, Boninfante A, Chae B, Carnevali A, Querques L, Bandello F, Querques G. Prevalence and Phenotypes of Age-Related Macular Degeneration in Eyes With High Myopia. Investigative Ophthalmology Visual Science. 60:1394-1402. 2019

122. Ghasemi Falavarjani K, Habibi A, Anvari P, Ghasemizadeh S, Ashraf Khorasani M, Shenazandi H, Sarraf D. Effect of segmentation error correction on optical coherence tomography angiography measurements in healthy subjects and diabetic macular oedema. British Journal Ophthalmology 2019.

123. Sacconi R, Sarraf D, Garrity S, Freund KB, Yannuzzi LA, Gal-Or O, Souied E, Sieiro A, Corbelli E, Carnevali A, Querques L, Bandello F, Querques G. Nascent Type 3 Neovascularization in Age-Related Macular Degeneration. Ophthalmology Retina. 2:1097-1106. 2018.

Case Reports

1. Sarraf D, Schwartz SD. Peculiar macular hemorrhage. Arch Ophthalmol 118:296-7, 2000.

D. Sarraf, 07 2019, of 57

2. Sarraf D, Jain A, Dubovy S, Fong D, Paschal J, Kreiger A. Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Retina 25:94-98, 2005.

3. Telander DG, Sarraf D. Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Sem Ophthalmol 22:151-3, 2007.

4. Win P, Gonzales C, Sarraf D. Syphilitic scleritis and choroidal malignant melanoma of the same eye. Sem Ophthalmol 22:193-5, 2007.

5. Jean-Francois E, Low J, Sarraf D. Sjogren-Larsson syndrome and crystalline maculopathy associated with a novel mutation. Arch Ophthalmol 125:1582-3, 2007.

6. Reddy S, Goldman DR, Kaines A, Hubschman JP, Sarraf D. Intracisternal irrigation of papavarine leading to choroidal infarction. Arch Ophthalmol 127:1550-1, 2009.

7. Reddy S,,Goldman DR, Hubschman JP, Kaines A, Sarraf D. Cocaine and choroidal infarction, revisiting the triangular sign of Amalric..Retinal Cases and Brief Reports 5:91-3, 2011.

8. Yuan A, Nusinowitz S, Sarraf D. Mizuo-Nakamura phenomenon with a negative waveform ERG. Br J Ophthalmol. 95:147-8, 2011.

9. Goldman D, Johnson M, Sarraf D. Posterior scleritis presenting as stellate neuroretinitis. Retinal Cases and Brief Reports 6:163-5, 2012.

10. Rahimy E and Sarraf D. Bevacizumab Therapy for Tamoxifen-Induced Crystalline Retinopathy and Severe Cystoid Macular Edema. Arch Ophthalmol 130:931-2, 2012.

11. Rahimy E, Sarraf D. Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound Paclitaxel Therapy. Ophthalmic Surg Lasers Imaging Retina. 44(2):1-3, 2013.

12. Rahimy E, Beardsley R, Ferrucci S, Ilsen P, Sarraf D. Optical coherence tomography findings in ocular argyrosis. Ophthalmic Surg Lasers Imaging Retina. 44:20-2, 2013.

13. Tsui I, Sarraf D. Paracentral acute middle maculopathy and acute macular neuroretinopathy. Ophthalmic Surg Lasers Imaging. Retina. 44(6 Suppl):S33-5,2013.

14. Joseph A, Rahimy E, Sarraf D. Bilateral Diffuse Uveal Melanocytic Proliferation With Multiple Iris Cysts. JAMA Ophthalmol. 132(6):787, 2014.

15. Joseph A, Rahimy E, Sarraf D. Peripheral retinal ischemia after intravenous tissue plasminogen activator for central retinal artery occlusion. Canadian J

D. Sarraf, 07 2019, of 57

Ophthalmol. 49(5):127-9, 2014.

16. Lin CF, Sarraf D. Best disease presenting as a giant serous pigment epithelial detachment. Retinal Cases and Brief Reports. 8(4):247-50, 2014.

17. Reed DC, Sarraf D. Multiple bilateral branch retinal artery occlusions in a patient with sickle cell disease with vancomycin red man syndrome. Retinal Cases and Brief Reports. 8(4):251-3, 2014.

18. Christenbury JG, Klufas MA, Sauer TC, Sarraf D. OCT Angiography of Paracentral Acute Middle Maculopathy Associated With Central Retinal Artery Occlusion and Deep Capillary Ischemia. Ophthalmic Surg Lasers Imaging Retina. 46(5):579-81, 2015.

19. Kuehlewein L, Sadda SR, Sarraf D. OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy. Eye. 29(7):932-5, 2015.

20. Nagiel A, Sadda SR, Schwartz SD, Sarraf D. Resolution of a giant pigment epithelial detachment with half-dose aflibercept. Retinal Cases Brief Reports. 9(4);269-72, 2015.

21. Curi AL, Sarraf D, Cunningham ET Jr. Multimodal imaging of syphilitic multifocal retinitis. Retinal Cases Brief Reports. 9(4);277-80, 2015.

22. Tan GS, Kuehlewein L, Sadda SR, Sarraf D, Schwartz SD. Subretinal neovascularization in macular telangiectasia type 2: optical coherence tomographic angiography and treatment response. Retinal Cases Brief Reports. 9(4):286-9, 2015.

23. Chen X, Kuehlewein L, Pineles SL, Tandon AK, Bose SX, Klufas MA, Sadda SR, Sarraf D. En face optical coherence tomography of macular microcysts due to optic neuropathy from neuromyelitis optica. Retin Cases Brief Reports. 9(4):302-6, 2015.

24. Klufas MA, O’Hearn T, Sarraf D. Optical coherence tomography angiography and widefield fundus autofluorescence in punctate inner choroidopathy. Retinal Cases Brief Reports. 9(4):323-6, 2015.

25. Sanfilippo CJ, Sarraf D. Congenital macrovessel associated with cystoid macular edema and an ipsilateral intracranial venous malformation. Retinal Cases Brief Reports. 9(4):357-9, 2015.

26. Sanfilippo CJ, Klufas MA, Sarraf D, Tsui I. Optical coherence tomography angiography of sickle cell maculopathy. Retinal Cases Brief Reports. 9(4):360-2, 2015.

27. Katsman D, Klufas MA, Sarraf D, Sadda S. Retinal Arterial Tortuosity in Moyamoya Disease. JAMA Ophthalmol. 134(1):111-4, 2016.

D. Sarraf, 07 2019, of 57

28. Yung, Madeline, Nicholas Iafe, and David Sarraf. Optical Coherence Tomography Angiography of a Retinal Astrocytic Hamartoma. Canadian Journal of Ophthalmology 51(2), 2016.

29. Wheatley HM, Sarraf D. Acute Macular Neuroretinopathy after Ranibizumab Injection in a Diabetic Patient. Retin Cases Bried Rep. 2016.

30. Sanfilippo CJ, Prasad P, Sarraf D. Retinal Vein Occlusion in a Patient with Maternally Inherited Diabetes and Deafness. Retin Cases Brief Rep. 2016.

31. Lenis TL, Klufas MA, Randhawa S, Sharma M, Sarraf D. Posterior Polar Annular Choroidal Dystrophy: A Case Series. Retin Cases Brief Rep. 2016.

32. Iafe NA, Law S, Sarraf D, Tsui I. Outer Retinal Folds Following Pars Plana Vitrectomy with Membrane Peel. Retina Cases Brief Rep. 2016.

33. Agange N, Sarraf D. Occult Macular Dystrophy with Mutations in the RP1L1 and KCNV2 Genes. Retin Cases Brief Rep. 2016.

34. Phasukkijwatana N, Rahimi M, Iafe N, Sarraf D. Optical Coherence Tomography Agiography of A29 Birdshot Chorioretinopathy Complicated by Retinal Neovascularization. Retin Cases Brief Rep. 2016.

35. Su D, Robson AG, Xu D, Lightman S, Sarraf D. Quinine Toxicity: Multimodal Retinal Imaging and Electroretinography Findings. Retin Cases Brief Rep. 2016.

36. Iafe NA, Onclinx T, Tsui I, Sarraf D. Paracentral Acute Middle Maculopathy and Deep Retinal Capillary Plexus Infarction Secondary to Reperfused Central Retinal Artery Occulsion. Retin Cases Brief Rep. 2016.

37. Dolz-Marco R, Sarraf D, Giovianazzo V, Freund KB. Optical coherence Tomography Angiography Shows Inner Choroidal Ischemia in Acute Posterior Multifocal Placoid Pigment Epitheliopathy. Retin cases Bried Rep. 2016.

38. Christenbury JG, Phasukkijwatana N, Tan A, Freund KB, Sarraf D. Dome-Shaped maculopathy: Enhanced Visualization with Radial Optical Coherence Tomography Scans. Retin Cases Brief Rep. 2016.

39. Su D, Xu D, Phasukkijwatana N, Sarraf D. En Face Optical coherence Tomography of Multiple Evanescent White Dot Syndrome. Retin Cases Brief Rep. 2016.

40. Nemiroff J, Phasukkijwatana N, Vaclavik V, Nagiel A, Holz ER, Sarraf D. The Spectrum of Amalric Triangular Choroidal Infarction. Retin Cases brief Rep. 2016.

41. Garrity ST, Holz EJ, Sarraf D. Amalric Triangular Syndrome Associated With Outer Nuclear Layer Infarction. Ophthalmic Surg Lasers Imaging Retina 2017.

D. Sarraf, 07 2019, of 57

42. Rabiolo A, Sacconi R, Giuffrè C, Corbelli E, Carnevali A, Querques L, Sarraf D, Freund KB, Sadda S, Bandello F, Querques G. Self-Inflicted Laser Handheld Laser-Induced Maculopathy: A Novel Ocular Manifestation Of Factitious Disorder. Retin Cases Brief Rep. 2017.

43. Gui W, Nusinowitz S, Sarraf D. Novel Cone Dystrophy With Central Ellipsoid Zone Loss Associated With Human Retinal Fascin Gene (Fscn2) Mutation. Retin Cases Brief Rep. 2017.

44. Essilfie JO, Sanfilippo CJ, Sarraf D. Bull's Eye Maculopathy With Mutations In Rds/Prph2 And Rom-1. Retin Cases Brief Rep. 2017.

45. Garrity ST, Tseng VL, Sarraf D. Paracentral Acute Middle Maculopathy In A Perivenular Fern-Like Distribution With En Face Optical Coherence Tomography. Retin Cases Brief Rep. 2017.

46. Rahimi M, Navajas EV, Sarraf D. Paraneoplastic Vitelliform Maculopathy Associated With Metastatic Melanoma. Retin Cases Brief Rep. 2017.

47. Xu D, Su D, Nusinowitz S, Sarraf D. Central Ellipsoid Loss Associated With Cone Dystrophy And Kcnv2 Mutation. Retin Cases Brief Rep. 2017.

48. Friesen ET, Phasukkijwatana N, Tsui I, Berkenstock MK, Holland GN, Sarraf D. Perivascular Granulomata In The Retina Demonstrated By En Face Optical Coherence Tomography In A Patient With Blau Syndrome. Retin Cases Brief Rep. 2017

49. Nemiroff J, Sarraf D, Davila JP, Rodger D. Optical Coherence Tomography Angiography Of Acute Macular Neuroretinopathy Reveals Deep Capillary Ischemia. Retinal Cases Brief Rep. 2018

50. Pichi F, Sarraf D. Optically Empty Choroidal Spaces In High Hyperopia. Retin Cases Brief Rep. 2018

51. Sebastiani S, Pellegrini M, Giannaccare G, Sarraf D. Paracentral Acute Middle Maculopathy Associated With Phosphodiesterase-5 Inhibitor Therapy. Retin Cases Brief Rep. 2018

52. Dean M, Kirschen D, Hubschman JP, Straatsma BR, Sarraf D, Francone A. Bilateral Acquired Progressive Retinal Nerve Fiber Layer Myelination. Ophthalmic Surg Lasers Imaging Retina. 49(10):e147-e150. 2018

Review Papers

D. Sarraf, 07 2019, of 57

1. Sarraf D, Lee DA. The role of iontophoresis in ocular drug delivery. J Ocular Pharmacol 10:69-81,1994.

2. Sarraf D, Ernest JT. Acquired Immune Deficiency and the Eyes. Lancet 348:525-8, 1996.

3. Jain A, Sarraf D, Fong DA. Preventing diabetic retinopathy through control of systemic risk factors. Current Opinion Ophthalmol 14(6):389-94, 2003.

4. Drenser K, Sarraf D, Jain A, Small KW. Crystalline Retinopathies. Surv Ophthalmol 51(6):535-49, 2006.

5. Chang L and Sarraf D. Current and future approaches to prevention and treatment of diabetic retinopathy. Clinical Ophthalmology 2:1-8, 2007.

6. Rahimy E and Sarraf D. Paraneoplastic and related retinopathies. Review of Ophthalmology (pp: 50-60), November 2011.

7. Rahimy E and Sarraf D. Paraneoplastic and non paraneoplastic retinopathy and optic neuropathy: Evaluation and management. Survey of Ophthalmology. 58(5):430-58, 2013.

8. Joseph T, Rahimy E, Freund KB, Sarraf D. Multimodal imaging in AMN. Retina Physician. June 2013.

9. Mrejen S, Sarraf D, Mukkamala SK, Freund KB. Multimodal imaging of pigment epithelial detachment: a guide to evaluation. Retina. 33(9):1735-62, 2013.

10. George M, Golchet P,Freund KB, Sarraf D. Multimodal imaging of APMPPE, related disorders. Review of Ophthalmology. 14:42-8, 2014.

11. Rahimy E, Sarraf D. Paracentral acute middle maculopathy spectral-domain optical coherence tomography feature of deep capillary ischemia. Current Opinion Ophthalmol. 25(3):207-12, 2014.

12. Nagiel A, Sadda SR, Sarraf D. A promising future for optical coherence tomography angiography. JAMA Ophthalmol. 133(6):629-30, 2015.

13. Rahimy E, Kuehlewein L, Sadda S, Sarraf D. Paracentral acute middle maculopathy: What we knew then and what we know now. Retina 35(10):1921-30, 2016.

14. Yung Madeline, Klufas Michael, Sarraf David. Clinical applications of fundus autofluorescence in retinal disease. International Journal of Retina and Vitreous. 2(12):2016.

15. Bhavsar KV, Lin S, Rahimy E, Joseph A, Freund KB, Sarraf D, Cunningham ET Jr. Acute Macular Neuroretinopathy: A Comprehensive Review of the Literature. Survey Ophthalmol. 2016.

D. Sarraf, 07 2019, of 57

16. Novais EA, Baumal CR, Sarraf D, Freund KB, Duker JS. Multimodal Imaging in Retinal Disease: A Consensus Definition. Ophthalmic Surg Lasers Imaging Retina. 1;47(3):201-5, 2016.

17. Nemiroff J, Phasukkijwatana N, Sarraf D. Optical Coherence Tomography Angiography of Deep Capillary Ischemia. Dev Ophthalmol. 56:139-45, 2016.

18. Iafe NA, Phasukkijwatana N, Sarraf D. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration. Dev Ophthalmol. 56:45-51, 2016.

19. Yung M, Sarraf D. Fundus Autofluorescence in Retinal Disease: A Review and Perspectives. Retinal Physician. 2016.

20. Yung M, Klufas MA, Sarraf D. Clinical Applications Of Fundus Autofluorescence In Retinal Disease. Int J Retina Vitreous. 2016.

21. Pichi F, Sarraf D, Arepalli S, Lowder CY, Cunningham ET Jr, Neri P, Albini TA, Gupta V, Baynes K, Srivastava SK. The Application Of Optical Coherence Tomography Angiography In Uveitis And Inflammatory Eye Diseases. Prog Retin Eye Res. 2017.

22. Falavarjani KG, Sarraf D. Optical coherence tomography angiography of the retina and choroid; current applications and future directions. J Curr Ophthalmol. 2017.

23. Brown D, Heier J, Sarraf D et al. Current Best Clinical Practices-Management of Neovascular AMD. Journal of Vitreoretinal Disease. 2017

24. Garrity ST, Paques M, Gaudric A, Freund KB, Sarraf D. Considerations in the Understanding of Venous Outflow in the Retinal Capillary Plexus. Retina. 2017.

25. Garrity ST, Sarraf D. The Arc of Change in Optical Coherence Tomographic Angiography Technology: Progression Toward Greater Reliability. JAMA Ophthalmol. 2017

26. Pichi F, Sarraf D, Morara M, Mazumdar S, Neri P, Gupta V. Pearls and pitfalls of optical coherence tomography angiography in the multimodal evaluation of uveitis. J Ophthalmic Inflamm Infect. 2017.

27. Khanani AM, Eichenbaum D, Schlottmann PG, Tuomi L, Sarraf D. Optimal Management Of Pigment Epithelial Detachments In Eyes With Neovascular Age-Related Macular Degeneration. Retina. 2018

28. Garrity ST, Sarraf D, Freund KB, Sadda SR. Multimodal Imaging of Nonneovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 20;59(4). 2018

D. Sarraf, 07 2019, of 57

29. Borrelli E, Sarraf D, Freund KB, Sadda SR. OCT angiography and evaluation of the choroid and choroidal vascular disorders. Prog Retin Eye Res. 67:30-55. 2018

30. Kovach JL, Isildak H, Sarraf D. Crystalline retinopathy: Unifying pathogenic pathways of disease. Surv Ophthalmol. 64(1):1-29. 2019

31. Gupta RR, Iaboni DSM, Seamone ME, Sarraf D. Inner, outer, and full-thickness retinal folds after rhegmatogenous retinal detachment repair: A review. Surv Ophthalmol. 2018

32. Au A, Sarraf D. Vascular anatomy and its relationship to pathology in retinoschisis. Eye (Lond). 2018

Chapters

1. Sarraf D, Schwartz J, Lee DA. Ocular Size and Shape. In The Eye In Infancy, Isenberg SJ (editor). Mosby-Year Book, pp:275-94, 1994.

2. Sarraf D. Retina and Vitreous. In Rudolph’s Pediatrics, 21 ed. Rudolph AM (editor). Appleton Lange, Norwalk, CT, pp. 2063-127, 2002.

3. Sarraf D, Coleman A. Visual Impairment. In: Geriatric Nursing Review Syllabus: A Core Curriculum in Geriatric Nursing. Kendall Hunt Publishing Company for the American Geriatrics Society, Dubuque, IA, 2003.

4. Mango C, Sarraf D, Schwartz SD. Choroidal Folds. In: Essentials of Ophthalmology. Holz F, Spaide R (editors). Springer-Verlag, Heidelberg, Germany, 2005.

5. Farzad S, Coleman A, Sarraf D. Visual Impairment. In Ambulatory Care Geriatrics, Editor Rosenthal T. Lippincott Williams & Wilkins, New York, 2005.

6. Giaconi J, Sarraf D, Coleman A. Visual Impairment. In: Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine, 5th and 6th and 7th and 8th eds. Durso SC, Sullivan GM, eds. New York, NY: American Geriatrics Society; 2002, 2006, 2010, 2013.

7. Rahimy E, Mrejen S, Freund KB, Sarraf D. Retinal Pigment Epithelium Detachment and Tear. In: Fundus Autofluorescence. Lois N and Forrester J (editors). Lippincott 2015.

8. Prasad P, Sarraf D. Wide Field Imaging of Retinal Dystrophies. In: Atlas of Wide-Field Retinal Angiography and Imaging, eds: Arevalo F and Kozak. Springer in 2015.

9. Iafe Nicholas, Phasukkijwatana N, Sarraf D. OCT Angiography of Type 1

D. Sarraf, 07 2019, of 57

Neovascularization. Springer 2016.

10. Nemiroff J, Phasukkijwatana N, Sarraf D. OCT Angiography of Deep Capillary Ischemia. Springer 2016.

11. Nicholas A. Iafe, Nopasak Phasukkijwatana, and David Sarraf. Optical Coherence Tomography Angiography and Neovascular Age-Related Macular Degeneration. Thieme (New York NY). 2017.

12. Garrity ST, Sarraf D, K Bailey Freund. A Multimodal Imaging Guide to the Evaluation and Management of Neovascular Age-Related Macular Degeneration. ESASO Course Series. Karger (Basil Switzerland) 2017.

13. Kirk K Hou, Adrian Au, Sean T Garrity, David Sarraf. Optical Coherence Tomography Angiography of Type 3 Neovascularization. ESASO Course Series. Karger (Basil Switzerland) 2019

14. David Xu, Juliet Essilfie, David Sarraf. Optical Coherence Tomography Abnormalities of the Retina that may Affect the Outcome of Cataract Surgery. Jaypee Brothers Medical Publishers. Delhi 2019

15. Xu David, Sarraf D. Acute Posterior Multifocal Placoid Pigment Epitheliopathy. In Retina Illustrated. Thiem.

16. Hilely A, Au Adrian, Sarraf D. Inflammatory CNV.

Books

1. K. Bailey Freund, David Sarraf, William F. Mieler, Lawrence Yannuzzi. The Retinal Atlas 2nd Edition. Elsevier 2016.

Author Reply

1. Sarraf D, Schwartz SD. Choroidal folds and neuropathy: author reply. Ophthalmol 110:2436, 2003.

2. Chiang A, Chang LK, Yu F, and Sarraf D. Predictors of anti-VEGF-associated RPE tears using FA and OCT analysis. Letter to Editor (author reply). Retina 29:124, 2009

3. Chan CK, Abraham P, Sarraf D. High-dose ranibizumab therapy for vascularized pigment epithelial detachment. Author Reply. Eye. 26:1600-1, 2012.

4. Pang CE, Sarraf D, Freund KB. Extreme choroidal thinning in high myopia. Author Reply. Retina. 35(8): e47-8, 2015.

5. Dansingani KK, Balaratnasingam C, Freund KB, Klufas MA, Sarraf D. Optical coherence tomography angiography of shallow irregular pigment epithelial

D. Sarraf, 07 2019, of 57

detachments in pachychoroid spectrum disease. Author Reply. Am J Ophthalmol. 163:193-4, 2016.

6. Pang CE, Sarraf D, Freund KB. Extreme choroidal thinning in high myopia Author Reply. Retina. 36(3), 2016.

7. Bhavsar KV, Freund KB, Sarraf D, Cunningham ET Jr. Author response: Optical coherence tomography angiography and retinal microvascular ramification in AMN and PAMM. Surv Ophthalmol. 2016.

8. Govetto A, Lalane RA 3rd, Sarraf D, Hubschman JP, Figueroa MS. Author Reply. Am J Ophthalmol. 2017.

9. Govetto A, Lalane RA 3rd, Sarraf D, Hubschman JP, Figueroa MS. Author reply. Am J Ophthalmol. 2017

10. Falavarjani KG, Freund KB, Sadda S, Sarraf D. Author Reply. Am J Ophthalmol. 2017.

11. Tan ACS, Freund KB, Sarraf D. Author Reply. Retina. 2018

12. Xu D, Dávila JP, Rahimi M, Rebhun CB, Alibhai AY, Waheed NK, Sarraf D. Long-term Progression of Type 1 Neovascularization in Age-related Macular Degeneration Using Optical Coherence Tomography Angiography. Author Reply. Am J Ophthalmol. 2018

13. Pichi F, Abboud EB, Sarraf D. Is the Association of Retinal Venous Malformations With Venous Malformations of the Brain Clinically Meaningful?-Reply. JAMA Ophthalmol. 136(12):1425. 2018

Miscellaneous Publications

1. Yuan A, Saulny S, Sarraf D. Lattice Degeneration. eMedicine Journal (serial online) 2(6), 2001.

2. Sarraf D. Diabetes and Eye Disease. A slide-script program. American Academy of Ophthalmology. San Francisco, CA. 2001.

3. Ussa F, Coco RM, Paulo JD, Ayllon W, Cuadrado R, Sarraf D, Margo CE, Friedman SM. Diagnostic and Therapeutic Challenges. Retina 30:1311-5, 2010.

4. Wu N, Liu X, Chen SJ, Sarraf D. Diagnostic and Therapeutic Challenges. Retina 33:443-6, 2013.

5. De Salvo G, Keane PA, Tufail A, Sarraf D. Diagnostic and Therapeutic Challenges.Retina. 2014.

D. Sarraf, 07 2019, of 57

6. Nagiel A, Sarraf D. A Triangular Syndrome. X-Files (Retina Times). May 2013.

7. Bhavsar K, Roybal N and Sarraf D. Familial Amyloidosis. X-Files (Retina Times). Fall 2014.

8. McDonald HR, Sadda S, Sarraf D. Editorial. Retin Cases Brief Rep. 8(4):235, 2014.

9. Dmuchowska DA, Zalewska R, Jasiewicz M, Krasnicki P, Mikita A, Sobkowicz B, Mariak Z, Sarraf D. Diagnostic and Therapeutic Challenges. Retina. 35(11):2417-20, 2015.

10. McDonald HR, Sadda S, Sarraf D. Editorial. Retinal Cases Brief Reports. 9(4):259, 2015.

11. Kuehlewein L, Sarraf D, Sadda S. OCT angiography in AMD. Retina Today. 2015 (June).

12. Cunha Souza E, Dolz-Marco R, de Franco Suzuki AC, Morita C, Sarraf D, Freund KB, Cohen SY. Diagnostic and Therapeutic Challenges. Retina. 2017.

13. McDonald HR, Sadda S, Sarraf D. Pacific Retina Club Meeting. Retin Cases Brief Rep. 2017.

INVITED LECTURES

1. Transscleral Iontophoresis Of Foscarnet. Alumni Day, Jules Stein Eye Institute, UCLA, 02/1993.

2. Familial Cavernous Hemangioma: An Expanding Ocular Spectrum. Grand Rounds, Moorfields Eye Hospital, 09/1997.

3. Diabetic Retinopathy. Grand Rounds, West Los Angeles VA Medical Center, 07/1998.

4. Choroidal Neovascularization. A Hard Beast To Tame. Resident Laser Course, Jules Stein Eye Institute, UCLA, 09/1998.

5. Diabetes and Pregnancy. American Society of Ophthalmic Registered Nurses, American Academy of Ophthalmology, 10/1999.

6. Phakomatoses: Old and New. Grand Rounds, Jules Stein Eye Institute, UCLA, 03/2000.

7. Ocular Manifestations of Systemic Disease. Internal Medicine Residency Lecture Series, David Geffen School of Medicine, UCLA, 03/2001.

8. The Jargon of ARMD: Deciphering the Code. Grand Rounds, Jules Stein Eye

D. Sarraf, 07 2019, of 57

Institute, UCLA, 01/2002.

9. The Red Eye. Internal Medicine Residency Lecture Series, David Geffen School of Medicine, UCLA, 04/2002.

10. Crystalline Maculopathy. Guest Lecture, University of Creteil, 08/2002.

11. Hills and Vallies in the Land of the Fundus. Grand Rounds, Jules Stein Eye Institute, UCLA, 01/2003.

12. New Crystalline Retinopathies. Annual Postgraduate Seminar, Jules Stein Eye Institute, UCLA, 04/2003.

13. Age-Related Macular Degeneration and Retinitis Pigmentosa: Siblings or Strangers. Grand Rounds, Jules Stein Eye Institute, UCLA, 10/2003.


15. OCT Imaging of Macular Disease. Grand Rounds, King/Drew Medical Center, Drew University School of Medicine, 11/2004.

16. OCT Imaging of Macular Disease. Grand Rounds, Jules Stein Eye Institute, UCLA, 02/2005.

17. Advancements in the Treatment of ARMD. Internal Medicine Rounds, Greater LA VA Healthcare System (Wadsworth), 06/2005.

18. Advancements in the Treatment of ARMD. International PXE Foundation, Los Angeles, CA, 10/2005.

19. Ophthalmology Introduction 101. Third Year UCLA Medical Students, David Geffen School of Medicine, UCLA, 11/2005.

20. IJT Type 2: a Dilemna to Diagnose, a Challenge to Treat. Grand Rounds, Jules Stein Eye Institute, UCLA, 01/2006.

21. Hereditary Retinal Degenerations. JSEI/SCCO Retina Symposium, Jules Stein Eye Institute, UCLA, 02/2006.

22. The Red Eye. Internal Medicine Residency Lecture Series, David Geffen School of Medicine, UCLA, 04/2006 and 06/2006.

23. Photodynamic Therapy and Mac Tel II. JSEI Clinical and Basic Science Seminar, Jules Stein Eye Institute, UCLA, 05/2006.

24. Visual Impairment in the Elderly. UCLA Geriatric Review Course, Los Angeles, CA, 09/2006.

D. Sarraf, 07 2019, of 57

25. RPE Rips: An Old Problem in a New Era. Grand Rounds, Jules Stein Eye Institute, UCLA, 11/2006.

26. RPE Rips: An Old Problem in a New Era. JSEI Clinical and Basic Science Seminar, Jules Stein Eye Institute, UCLA, 05/2007.

27. Retinitis. Grand Rounds, King-Harbor Medical Ctr, Drew University School of Medicine, 06/2007.

28. The Controversies and Conflicts of Off-label Avastin Therapy. Grand Rounds, Jules Stein Eye Institute, UCLA, 01/2008.


30. FA and OCT Predictors of RPE Tears Associated with Anti-VEGF Therapy in AMD. JSEI Clinical and Basic Science Seminar, Jules Stein Eye Institute, UCLA, 05/2008.

31. Vision Loss in the Elderly. UCLA Geriatric Review Course, Los Angeles, CA, 09/2008.

32. FA and OCT Predictors of RPE Tears Associated with Anti-VEGF Therapy in AMD. Retina Society, Scottsdale, Az, 09/2008.

33. A New Classification System for RPE tears. Grand Rounds, Jules Stein Eye Institute, UCLA, 01/2009.


35. Vision Loss in the Elderly. UCLA Geriatric Review Course, Los Angeles, CA, 09/2009.


37. Triamcinolone Associated Crystalline Maculopathy. JSEI Clinical and Basic Science Seminar, Jules Stein Eye Institute, UCLA, 05/2010.

38. Avastin versus Lucentis: Conflicts and Controversies. VI International Ophthalmology Course, University of Chile, Santiago, 07/2010.

39. Current and Future Approaches in the Prevention and Management of Diabetic Retinopathy. VI International Ophthalmology Course, University of Chile, Santiago, 07/2010.

40. White Dot Syndromes of the Retina. VI International Ophthalmology Course, University of Chile, Santiago, 07/2010.

D. Sarraf, 07 2019, of 57

41. The Management of Retinitis. VI International Ophthalmology Course, University of Chile, Santiago, 07/2010.

42. Systemic Agents and Retinal Toxicity. VI International Ophthalmology Course, University of Chile, Santiago, 07/2010.

43. Triamcinolone Associated Crystalline Maculopathy. ASRS (Vancouver). August 2010

44. A New Grading System for RPE Tears. Macula Society (Boca Raton. March 2011

45. The diagnosis, classification and management of PED and RPE tear. Invited Guest Speaker at University of Chicago Resident Research Day. June 2011

46. Advances in evaluation and treatment of central retinal vein occlusion and branch retinal vein occlusion. Invited Guest Speaker: Kaiser Permanente Ophthalmology Symposium, June 2011

47. A New Grading System for Posterior Staphyloma and Correlation with Macular Complications Including Myopic Macular Schisis. Retina Society (Rome), September 2011

48. Systemic Agents You Did Not Know Caused Retinal Toxicity. Invited Guest Speaker. Fundacion Oftalmologica Nacionale 3rd Annual Course, Columbia. March 2012.

49. Crystalline Retinopathy: All That Glitters Is Not Gold. Invited Guest Speaker. Fundacion Oftalmologica Nacionale 3rd Annual Course, Columbia. March 2012.

50. A New Grading System for Posterior Staphyloma and Correlation with Macular Complications Including Myopic Macular Schisis. Invited Guest Speaker. Fundacion Oftalmologica Nacionale 3rd Annual Course, Columbia March 2012.

51. Predictors of RPE Tear After AntiVEGF therapy for Wet ARMD. Invited Guest Speaker. Fundacion Oftalmologica Nacionale 3rd Annual Course, Columbia March 2012.

52. The Red Eye. Internal Medicine Residency Lecture Series, David Geffen School of Medicine, UCLA, April 2012.

53. Prospective Evaluation of the Incidence of RPE Tears and Analysis of the Baseline Risk Factors Predisposing to RPE tears in Eyes with PED and Exudative ARMD. Macula Society (Jerusalem). June 2012

54. Acute Macular Neuroretinopathy (AMN): New Insights into Diagnosis, Natural History and Pathogenesis as Revealed by Sequential Multimodal Imaging.

D. Sarraf, 07 2019, of 57

ASRS (Las Vegas), August 2012.

55. Vascularized Pigment Epithelial Detachment Treated with 0.5 mg versus 2 mg Ranibizumab: Analysis of Results Based on Lesion Subtypes. Retina Society (Washington DC), September 2012.

56. PED:Evaluation and Management by Multimodal Imaging. Invited guest speaker: Henry Ford Hospital, Detroit. January 2013.

57. Paracentral Acute Middle Maculopathy:A New Variant of AMN. Invited guest speaker: Henry Ford Hospital, Detroit. January 2013.

58. New Findings with SD OCT of PED in AMD. International Retinal Imaging Symposium (IRIS). Jules Stein Eye Institute, UCLA February 26, 2013.

59. Multilayered PED:A New SD OCT Finding in AMD. Macula Society (Dana Point CA), March 2013.

60. Systemic Agents You Did Not Know Caused Retinal Toxicity. 6th French American Ophthalmology Symposium. San Francisco April 18, 2013

61. Multimodal Imaging of ASPPC. An International Perspective. 6th French American Ophthalmology Symposium. San Francisco 04/18/2013

62. New SDOCT Findings of PED in AMD. 6th French American Ophthalmology Symposium. San Francisco April 18, 2013

63. RPE Tears: How, When, and Why do These Occur, and How do you Treat? AVTT. Chicago IL. August 2013

64. New SD-OCT Findings of PED in AMD. AVTT. Chicago IL. August 2013.

65. Multimodal Imaging and The White Dot Syndromes. AVTT. Chicago IL. August 2013.

66. Paraneoplastic and Autoimmune Retinopathy: Evaluation and Management. AVTT. Chicago IL. August 2013.

67. Syphilitic Retinitis: An International Perspective. AVTT. Chicago IL. August 2013.

68. Paracentral Acute Middle Maculopathy. Retina Society (Los Angeles, CA), 2013.

69. Diagnosis and Management of PED in AMD. Advanced Retinal Teaching. Vienna Austria. November 2013.

70. When Do I Use EDI. AAO Subspecialty Day. New Orleans LA. November 2013.

D. Sarraf, 07 2019, of 57

71. SD-OCT Imaging of Ischemia of the Superficial and Deep Capillary Plexus. IRIS II New York June 2014.

72. SD-OCT Analysis of deep capillary plexus ischemia in central retinal vein occlusion. ASRS. San Diego, 2014.

73. The Choroid and CSCR. Nordic Congress of Ophthalmology. Stockholm. August 2014

74. What’s New in the Assessment of AMD. Nordic Congress of Ophthalmology. Stockholm. August 2014.

75. Ischemia of the deep capillary plexus using SD OCT analysis. Kaiser Symposium. Anaheim. September 2014

76. PED with Type 1 versus Type 3 Neovascularization. Kaiser Symposium. Anaheim. September 2014

77. Analysis of birdshot chorioretinopathy abnormalities using SD-OCT and fundus autofluorescence imaging. Retina Society (Philadelphia PA), September 2014.

78. Evolution of Type 3 neovascularization and association with PED. Atlantic Retina Coast Conference and Macula 2015. Boston. January 2015.

79. PED and Type 1 and 3 neovascularization: an SD OCT and OCTA analysis. SCCO Conference. Riverside. January 2015

80. Type 1 versus Type 3 neovascularization: An SD OCT and OCTA analysis. USC Frontiers of OCT. Pasadena. February 2015.

81. Visual and Anatomic Outcomes of Large PEDs Following Ranibizumab Therapy in Wet AMD Patients: Subgroup Analysis of the HARBOR Study. Macula Society (Scottsdale). February 2015

82. Type 1 versus Type 3 neovascularization: An SD OCT and OCTA analysis. International Retinal Imaging Symposium (IRIS) III. Los Angeles. March 2015.

83. Type 1 versus Type 3 neovascularization: An SD OCT and OCTA analysis. Brazilian Retina and Vitreous Congress. Florianopolis (Brazil). April 2015

84. Paracentral Acute Middle Maculopathy. Brazilian Retina and Vitreous Congress. Florianopolis (Brazil). April 2015

85. Protocol T Results for the DRCR Net. Author Lee Jampol. Discussant David Sarraf. AOS. Newport RI. May 2015

86. OCT angiography of type 3 neovascularization. Incorporation of OCT

D. Sarraf, 07 2019, of 57

Angiography into clinical practice, drug development and clinical trials: opportunities and pitfalls. Rome. June 2015

87. Evaluation and management of PED in the antiVEGF era. Canadian Ophthalmological Society, Victoria BC, June 2015

88. OCT angiography of type 1 and 3 neovascularization. Canadian Ophthalmological Society, Victoria BC, June 2015

89. Spectrum of retinal toxicity using multimodal imaging. Canadian Ophthalmological Society, Victoria BC, June 2015

90. OCT angiography of deep capillary ischemia and paracentral acute middle maculopathy. Canadian Ophthalmological Society, Victoria BC, June 2015

91. Advanced retinal imaging of the white dot syndromes. 7th French American Ophthalmology Symposium. Monaco. June 2015

92. OCT angiography of type 1 and 3 neovascularization. Maculart, Paris France, June 2015

93. OCT angiography of deep capillary ischemia and paracentral acute middle maculopathy. Maculart. Paris France. June 2015

94. Genotype and phenotype correlation in hereditary retinal degenerations. Sally Letson Symposium. Ottawa Canada. September 2015

95. The utility of fundus autofluorescence and multimodal imaging. Sally Letson Symposium. Ottawa Canada. September 2015

96. Overview and current treatment of DME. Sally Letson Sympsoium. Ottawa Canada. September 2015

97. Autofluorescence. AAO Subspecialty Day. Las Vegas NV, November 2015.

98. What about atrophy when treating neovascular AMD? Macula Society Symposium, AAO, Las Vegas NV 2015.

99. What about atrophy when treating neovascular AMD? Best Papers Symposium, AAO, Las Vegas NV 2015

100. Evaluation and management of PED in the antiVEGF era. Korean Retina Congress. Seoul South Korea, December 2015

101. OCT angiography of type 1 versus type 3 neovascularization. Korean Retina Congress. Seoul South Korea, December 2015

102. OCT angiography of PAMM and deep capillary ischemia. Korean Retina Congress. Seoul South Korea, December 2015

D. Sarraf, 07 2019, of 57

103. Quantitative OCT angiography of type 1 and type 3 neovascularization. Third International En Face OCT and OCT Angiography Congress. Rome Italy, December 2015

104. OCT angiography of the deep retinal plexus in PAMM and normals. Third International En Face OCT and OCT Angiography Congress. Rome Italy, December 2015

105. En Face OCT and OCT angiography of MEWDS: An International Colloboration. Third International En Face OCT and OCT Angiography Congress. Rome Italy, December 2015.

106. OCT angiography of the deep capillary plexus: present limitations and future applications. Third International En Face OCT and OCT Angiography Congress. Rome Italy, December 2016.

107. Evaluation and management of PED in the antiVEGF era. Hawaiian Eye. Hawaii, January 2016.

108. OCT angiography of type 1 versus type 3 neovascularization. Hawaiann Eye. Hawaii. January 2016.

109. Advanced imaging of the white dot syndromes. Hawaiann Eye. Hawaii. January 2016.

110. OCT angiography of deep capillary ischemia. Atlantic Coast Retina Club. Macula 2016. New York NY. January 2016.

111. OCT Angiography of type 1 versus type 3 neovascularization after antiVEGF therapy. Ocular Angiogenesis, Degeneration and Exudation. Miami Fl, February 2016.

112. OCT Angiography of type 1 versus type 3 neovascularization after antiVEGF therapy. Macula Society. Eden Roc Fl, February 2016.

113. Type 3 Neovascularization: A New Staging System. IRIS IV (International Retina Imaging Symposium). Los Angeles CA. March 2016.

114. Type 1 versus type 3 neo with PED: A prospective analysis. San Rafael OCT Forum. Milan CA, April 2016.

115. SD OCT and OCTA of type 3 neo. San Rafael OCT Forum. Milan CA, April 2016.

116. OCTA of white dot syndromes. San Rafael OCT Forum. Milan CA, April 2016.

117. Efficacy Of Ranibizumab Therapy in Eyes With Neovascular AMD and

D. Sarraf, 07 2019, of 57

Pigment Epithelial Detachment: a HARBOR Subanalysis Study. ARVO. Seattle WA. May 2016.

118. OCT angiography of neovascularization in AMD. ARVO. Seattle WA. May 2016.

119. OCT Angiography of Type 1 versus Type 3 neovascularuzation in AMD after antiVEGF therapy. AOS. Colorado Springs, CO. May 2016.

120. OCT Angiography for the Evaluation of Macular Disease and En Face OCT and OCTA of White Dot Syndromes. UC Colorado (Denver). Denver, Colorado. May 2016.

121. Impact of OCTA on our Understanding of AMD: Biology and Management. UCLA Stein Eye Institute Clinical AND Research Seminar. Los Angeles CA. June 2016.

122. Imaging in Retinal Vascular Diseases: Diabetic Retinopathy and Other Causes of PAMM and Deep CapillaryIschemia. Cole Eye Institute Imaging Summit. San Francisco CA. August 2016

123. Advanced Imaging of the White Dot Syndromes Including MEWDS and the Placoid Related Disorders. Cole Eye Institute Imaging Summit. San Francisco CA. August 2016

124. Advanced Retinal Imaging of the White Dot Syndromes. AVTT. Chicago IL. August 2016.

125. The Importance of Atrophy in Neovascular AMD. AVTT. Chicago IL. August 2016.

126. New Classification System for Type 3 Neovascularization. AVTT. Chicago IL. August 2016.

127. Evaluation and Management of Dome-Shaped Macula in Myopia. AVTT. Chicago IL. August 2016.

128. OCT Angiography: Clincial Applications and Beyond. Vanderbilt Eye Institute. Nashville TN. August 2016.

129. Imaging in Retinal Vascular Disease: Diabetic Retinopathy and Other Causes of PAMM and Deep Capillary Ischemia. Cole Eye Institute Imaging Summit. San Francisco CA. August 2016.

130. Advanced Imaging of the White Dot Syndromes Including MEWDS and the Placoid Related Disorders. Cole Eye Institute Imaging Summit. San Francisco CA. August 2016.

131. Specialized SD-OCT in Uveitis- En Face and OCT-A (Retina and Choroid).

D. Sarraf, 07 2019, of 57

Sally Letson Symposium 48th Annual Meeting. Ottawa Canada September 2016

132. Widefield Color, Angiographic and Autofluorescence Imaging. Sally Letson Symposium 48th Annual Meeting. Ottawa Canada September 2016.

133. Paraneoplastic Retinopathies. Sally Letson Symposium 48th Annual Meeting. Ottawa Canada September 2016.

134. Optical Coherence Tomography Angiography of Placoid Related Disorders. Retina Society. San Diego CA September 2016.

135. Fundus Autofluorescence. Retina Society Symposium. AAO. Chicago IL September 2016.

136. Atrophy and Type 1 Neovascularization: An en face OCT and OCTA Analysis. Retinal Imaging Symposium in the Himalayas (RISHI). Chandigarh, India November 2016.

137. PED Associated with Type 1 versus Type 3 Neovascularization: an SD OCT and OCTA Analysis. Retinal Imaging Symposium in the Himalayas (RISHI). Chandigarh, India November 2016.

138. Mac Tel & Rap – “Fine Vessel” Diseases. Vitreo Retina Society India. Chandigarh, India November 2016.

139. PAMM- Decoding the Disease. Vitreo Retina Society India. Chandigarh, India November 2016.

140. Primary Treatment of Diabetic Macular Edema. Vitreo Retina Society India. Chandigarh, India November 2016.

141. OCT-A: Latest Advances at the International Level and Clinical Use in Daily Practice. Novartis Symposium. Creteil, France December 2016.

142. What OCT-Angiography Has Already Brought to the Retina: Latest Developments. Novartis Symposium. Paris, France December 2016.

143. Another Point of View: WAMD Management in the USA. Novartis Symposium. Paris, France December 2016.

144. Another Point of View: DME Management in the USA. Novartis Symposium. Paris, France December 2016.

145. Another Point of View: RVO Management in the USA. Novartis Symposium. Paris, France December 2016.

146. OCT Angiography: Latest Developments and Use in Clinical Practice. Novarits Symposium. Hopital La Croix Rousse. Lyon, France December 2016.

D. Sarraf, 07 2019, of 57

147. Clinical Applications of OCTA and Beyond. Novartis Symposium. Marseille, France December 2016.

148. New Explorations in Medical Retina: Focus on OCT-Angio. Novartis Symposium. Marseille, France December 2016.

149. Optical Coherence Tomographic Angiography Compared with Fluorescein Angiography in Different Retinopathies and Follow-Up of Different Neovascularization Type Under Anti-VEGF Treatment. Novartis Symposium. Lyon, France December 2016.

150. OCT Angiography Analysis of Type 1,2,3,4 Neovascularization. 4th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2016.

151. OCT-A Characteristics of Vascularized PED in AMD. 4th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2016.

152. A New Staging of Type 3 Neovascularization Using Spectral Domain OCT. 4th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2016.

153. OCT Angiography of Type 1 Neovascularization Associated with macular Atrophy. 4th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2016.

154. SD OCT and OCTA of PAMM Versus AMN. 4th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2016.

155. OCT Angiography of Placoid Related Disorders Shows Choriocapillaris Ischemia. 4th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2016.

156. Biomarkers of Neovascular Activity Using OCT Angiography. Angiogenesis, Exudation, and Degeneration 2017. Miami, FL February 2017.

157. Panel Moderator: Optical Coherence Tomography (OCT) Angiography: Where Am I Using It? Has It Changed My Outcomes? What Am I Learning From It? Retina World Congress 2017. Ft Lauderdale, FL February 2017.

158. Best Imaging Techniques for AMD. Retina World Congress 2017. Ft Lauderdale, FL February 2017.

159. The Spectrum of Retinal Toxicity: From the Odd to the Ordinary. University of Manitoba Retina and Imaging Visiting Professor Resident Teaching 2017. Winnipeg, Canada March 2017.

160. OCT Angiography: Clinical Applications and Beyond. University of Manitoba Retina and Imaging Visiting Professor Resident Teaching 2017. Winnipeg,

D. Sarraf, 07 2019, of 57

Canada March 2017.

161. Advanced Retinal Imaging of the White Dot Syndromes. University of Manitoba Retina and Imaging Visiting Professor Resident Teaching 2017. Winnipeg, Canada March 2017.

162. Biomarkers of Neovascular Activity in AMD Using OCTA Aanalysis. 3rd San Raffaele OCT Forum 2017. Milan, Italy March 2017.

163. Panel Discussion. 3rd San Raffaele OCT Forum 2017. Milan, Italy March 2017.

164. Type 3 Neovascularization: Origin, Evolution, and Long-Term Response to Therapy. 3rd San Raffaele OCT Forum 2017. Milan, Italy March 2017.

165. En Face OCT Analysis of PAMM and Deep Capillary Ischemia. 3rd San Raffaele OCT Forum 2017. Milan, Italy March 2017.

166. En Face OCT Analysis of PAMM and Deep Capillary Ischemia. 5th Annual International Retinal Imaging Symposium. Los Angeles March 2017.

167. Panel Moderator. 5th Annual International Retinal Imaging Symposium. Los Angeles March 2017.

168. The Deep Capillary Plexus: the Importance of What Lurks Beneath. 42nd Congress of the Brazilian Retinal and Vitreous Society 2017. Rio de Janeiro, Brazil April 2017.

169. The New Frontier of OCT Angiography: Clinical Applications. 42nd Congress of the Brazilian Retinal and Vitreous Society 2017. Rio de Janeiro, Brazil April 2017.

170. En Face OCT of PAMM. 42nd Congress of the Brazilian Retinal and Vitreous Society 2017. Rio de Janeiro, Brazil April 2017.

171. Panel Discussion: BRAVS Panel 1 - Medical Maculopathy. 42nd Congress of the Brazilian Retinal and Vitreous Society 2017. Rio de Janeiro, Brazil April 2017.

172. Panel Discussion: BRAVS Panel 7 – Imaging. 42nd Congress of the Brazilian Retinal and Vitreous Society 2017. Rio de Janeiro, Brazil April 2017.

173. Panel Discussion: Medical Case 2. 42nd Congress of the Brazilian Retinal and Vitreous Society 2017. Rio de Janeiro, Brazil April 2017.

174. Diabetic Macular Edema (DME) Management: Trends and Challenges. Novartis Speakers Bureau, 42nd Congress of the Brazilian Retinal and Vitreous Society 2017. Rio de Janeiro, Brazil April 2017.

175. Retinal Vein Occlusions (RVO) Management: Trends and Challenges.

D. Sarraf, 07 2019, of 57

Novartis Speakers Bureau, 42nd Congress of the Brazilian Retinal and Vitreous Society 2017. Rio de Janeiro, Brazil April 2017.

176. Type 3 Neovascularization. Mayo Clinic. Rochester Minnesota. April 2017.

177. Clinical Applications of OCT Angiography. Mayo Clinic. Rochester Minnesota. April 2017.

178. Choriocapillaris Flow Deficits Using OCT Angiography. ARVO Imaging Symposium. Baltimore MD May 2017.

179. En Face OCT and OCT Angiography to Assess the Spectrum of Perivenular Ischemia and Paracentral Acute Middle Maculopathy in Retinal Vein Occlusion. American Ophthalmological Society. Hot Springs Virginia. May 2017

180. Biomarkers of Neovascularization using OCT Angiography. Maculart. Paris. France. June 2017.

181. OCT Angiography of Flow Deficits in Myopia. Maculart. Paris France. June 2017.

182. How do I use En Face Imaging in Clinical Practice? Cole Eye Institute Imaging Summit 2017. Boston August 2017.

183. When is OCT not enough? The importance of multimodal imaging. Cole Eye Institute Imaging Summit 2017. Boston August 2017.

184. OCT Angiography in Clinical Practice. American Society of Retina Specialists 35th Annual Meeting 2017. Boston August 2017.

185. En Face OCT and OCT Angiography to Assess the Spectrum of Perivenular Ischemia and Paracentral Acute Middle Maculopathy in Retinal Vein Occlusion. American Society of Retina Specialists 35th Annual Meeting 2017. Boston August 2017.

186. Long-Term Biomarkers of Neovascularization Using OCT Angiography. University of British Columbia. Vancouver BC September 2017.

187. What is The Rap on RAP: Type 3 Noevascularization. University of British Columbia. Vancouver BC September 2017.

188. Choriocapillaris Flow Deficits with OCT Angiography. Retina Society. Boston MA. October 2017.

189. Aflibercept for Non AMD indications. Amgen. Thousand Oaks CA. October 2017.

190. New Biomarkers of Angiogenesis. AAO Subspecialty Day. New Orleans. November 2017.

D. Sarraf, 07 2019, of 57

191. Fundus Autofluorescence and Clinical Applications. AAO Symposium. New Orleans. November 2017.

192. Spotlight on Posterior Segment Imaging. Symposium Chair. AAO. New Orleans. November 2017.

193. En Face OCT: An Underutilized Tool to Interpret Retinal Disease. AAO New Orleans. November 2017.

194. Novel Discoveries of OCTA. AAO Doheny Symposium. New Orleans. November 2017.

195. OCTA Biomarkers of Type 1 NV Activity. 5th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2017.

196. Macular Microcysts and Muller cell Disruption. 5th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2017.

197. New Concepts in the Understanding of Venous Outflow in the Retinal Capillary Plexus. 5th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2017.

198. OCTA Imaging of the Choriocapillaris in placoid Disorders. 5th International Congress OCT Angiography and Advances in OCT. Rome, Italy December 2017.

199. Understanding Retinal Capillary Flow and the Implications for Macular Disease. Research Study Club of LA. January 2018.

200. What have we learned about the choriocapillaris in posterior segment disease. Imaging Meeting. Bozen Italy. February 2018.

201. New Concepts in Understanding Venous Drainage in the Retinal Capillary Plexus using OCT Angiography. APAO. Hong Kong. February 2018

202. Biomarkers of Neovascular Activity in AMD using OCT Angiography. APAO. Hong Kong. February 2018.

203. The Retinal Capillary Plexus is In Series. INTRIS 2018. Los Angeles CA February 2018.

204. OCT and Histopathological Analysis of the Tractional Abnormalities of the Central Foveal Bouquet Associated with Epiretinal Membrane Formation. Macula Society. Los Angeles CA February 2018.

205. The Muller Cell: A Pivotal Player in Macular Disease. Pittsburgh Ophthalmological Society. Pittsburgh PA 03 2018

206. Understanding Venous Outflow in the Retinal Capillary Plexus. Pittsburgh

D. Sarraf, 07 2019, of 57

Ophthalmological Society. Pittsburgh PA 03 2018

207. OCT Angiography of Type 3 NV: Linking the Deep Capillary Plexus and the Choroid. Fourth Annual San Raffaele OCT Retina Forum. Milan Italy. 04 2018

208. Advanced Retinal Imaging of Epiretinal Membranes. New Concepts and Mechanisms. Fourth Annual San Raffaele OCT Retina Forum. Milan Italy. 04 2018

209. Exploring the Importance of the Muller Cell in Macular Disease. Fourth Annual San Raffaele OCT Retina Forum. Milan Italy. 04 2018

210. The Muller Cell: A Pivotal Player in Macular Disease. LuEsther T Mertz Lectureship. New York NY 04 2018

211. OCT and Histopathological Analysis of the Tractional Abnormalities of the Central Foveal Bouquet Associated with ERM formation. ARVO. Honolulu HI. 04 2018.

212. Optical Coherence Tomography Angiography of Collateral Vessel Formation in Eyes with Retinal Vein Occlusion Supports Venous Outflow Origin in the Deep Vascular Complex. AOS. Dana Point CA. 05 2018

213. Determining The Prevalence Of PCV In Anti-Vegf Resistant Eyes And The Sensitivity And Specificity Of Detecting PCV With En-Face OCT and OCTA. Author Greg Kokame. Discussant David Sarraf. AOS. Dana Point CA 05 2018

214. Is the Retinal Capillary Plexus Arranged In Series or In Parallel. 29TH Annual Loyola Ophthalmology Resident Alumni Day. Chicago IL. 06 2018

215. The Muller Cell: A Pivotal Player in Macular Disease. Mark Daily Lectureship Award. 29TH Annual Loyola Ophthalmology Resident Alumni Day. Chicago IL. 06 2018

216. Clinical Applications and Limitations of OCT Angiography. MOAC. Chiang Mai, Thailand. 06 2018

217. Advanced Retinal Imaging Supports an In Series Organization of the Retinal Capillary Plexus. Cole Eye Imaging Summit. Vancouver. 08 2018

218. The Importance of the Muller Cell in Macular Disease. Cole Eye Imaging Summit. Vancouver. 08 2018

219. Basics and Principles of OCT Angiography. AVTT. Chicago IL 08 2018.

220. Understanding Venous Drainage in the Retinal Capillary Plexus. AVTT. Chicago IL 08 2018.

221. Advanced retinal Imaging of Type 3 NV. AVTT. Chicago IL. 08 2018.

D. Sarraf, 07 2019, of 57

222. Hydroxy Chloroquine Montoring from A to Z. Chicago IL 08 2018.

223. RAP: Origin, Evolution, and Response of Type 3 NV using Advanced Retinal Imaging. 10th Annual Atlantic Eye Symposium. Halifax NS 09 2018.

224. OCT Angiography. Is it Ready for Prime Time? 10th Annual Atlantic Eye Symposium. Halifax NS 09 2018. Halifax NS 09 2018.

225. Agents Associated with Retinal Toxicity. A Current Update. 10th Annual Atlantic Eye Symposium. Halifax NS 09 2018. Halifax NS 09 2018.

226. Evaluation and Management of PED in Neovascular AMD in the anti VEGF Era. Bayer Symposium. 10th Annual Atlantic Eye Symposium. Halifax NS 09 2018.

227. Pearls and Pitfalls of OCT Angiography. Keynote Lecture. Toronto Ocular Imaging Symposium. Toronto ON. 09 2018

228. Advanced Retinal Imaging of PAMM and the Ischemic Cascade. Toronto Ocular Imaging Symposium. Toronto ON 09 2018

229. Evaluation and Management of PED in Neovascular AMD in the anti VEGF Era. Novartis Symposium. Toronto ON. 09 2018.

230. Cilioretinal Insufficiency and its Association with PAMM. Retina Society. San Francisco CA 09 2018.

231. OCT Angiography in Neovascular AMD. Ophthalmic Imaging: From Theory to Current Practice. Paris France 10 2018.

232. Advanced Retinal Imaging of Type 3 NV. Ophthalmic Imaging: From Theory to Current Practice. Paris France 10 2018.

233. Evaluation and Management of PED in Neovascular AMD. Novartis Symposium. Creteil University. Paris France. 10 2018

234. OCT Angiography: Is it Ready for Prime Time? Novartis Symposium. Bordeaux University. Bordeaux France. 10 2018

235. PAMM and the Ischemic Cascade. Novartis Symposium. Lariboisiere University. Paris France. 10 2018.

236. Mitochondrial Maculopathy. AAO Subday. Chicago IL. 10 2018

237. Is OCT Angiography Ready for Prime Time. Emerging Trends and Hot Topics in Ophthalmology. Doheny Eye Institute. AAO. Chicago IL. 10 2018

238. OCT Angiography. Macula Society Symposium. AAO. Chicago IL. 10 2018

D. Sarraf, 07 2019, of 57

239. Anti VEGF Therapy Causes Macula Atrophy. The Great Debate. AAO. Chicago IL. 10 2018

240. Pearls and Pitfalls of OCT Angiography. New York Eye and Ear Infirmary. New York NY 10 2018

241. AMD Masquerades : Don’t get fooled again. RISHI. Jaipur India. 11 2018

242. 3D OCTA volumetric analysis of PED in neovascular AMD. RISHI. Jaipur India. 11 2018

243. En Face OCT: Advanced Retinal Imaging of Macular Disease. VRSI. Jaipur India. 11 2018

244. Early identification of Plaquenil toxicity using Advanced Retinal imaging. VRSI. Jaipur India. 11 2018

245. OCTA Classification of NV in AMD. 6th International Congress on OCT Angiography and Advances in OCT Rome Italy. 12 2018

246. RAP: Advanced Retinal imaging of Type 3 NV. Keynote Lecture. 6th International Congress on OCT Angiography and Advances in OCT Rome Italy. 12 2018

247. OCT and OCTA Evaluation of the Mechanism of RPE Tears Associated with PED. 6th International Congress on OCT Angiography and Advances in OCT Rome Italy. 12 2018

248. The Ischemic Cascade in the Retinal Capillary Plexus. 6th International Congress on OCT Angiography and Advances in OCT Rome Italy. 12 2018

249. Summary of the Clinical Implications of Muller Cell Maculopathy. 6th International Congress on OCT Angiography and Advances in OCT Rome Italy. 12 2018

250. Pathoanatomical Considerations in Evaluation of the Choriocapillaris and Choroid. 6th International Congress on OCT Angiography and Advances in OCT Rome Italy. 12 2018

251. The Retinal Capillary Plexus Is Organized In Series. 6th International Congress on OCT Angiography and Advances in OCT Rome Italy. 12 2018

252. PAMM and The Ischemic Cascade. ACRC. Massachussetts Eye and Ear Infirmary. Boston MA. 01 2019

253. 3D Volumetric Analysis of PED Progression in AMD using OCT Angiography. Macula Society. Bonita Springs FL. 02 2019

D. Sarraf, 07 2019, of 57

254. New Classification Schemes for AMD Using Advanced OCT Imaging. Canadian Retina Society. Whistler BC. 03 2019

255. Is OCT Angiography Ready for Prime Time: A Guide to Interpretation and Analysis. CRS. Whistler BC. 03 2019

256. Does Anti-VEGF therapy cause Geographic Atrophy? CRS. Whistler BC. 03 2019

257. PAMM and the Ischemic Cascade: New Concepts in the Pathoanatomy of the Retinal Capillary Plexus. CRS. Whistler BC 03 2019

258. En Face OCT Identification of New Foveal Anatomical Landmark. INTRIS 2019. SEI/UCLA. Los Angeles CA. 03 2019

259. New Observations about the Pathoanatomy of Macular Disease using En Face OCT. Fifth Annual San Raffaele OCT Retina Forum. Milan Italy. 03 2019

260. PAMM and the Ischemic Cascade. New Concepts in the PathoAnatomy of the Retinal Capillary Plexus. Fifth Annual San Raffaele OCT Retina Forum. Milan Italy. 03 2019

261. PAMM and the Ischemic Cascade. New Concepts in the PathoAnatomy of the Retinal Capillary Plexus. Sonoma Eye. Sonoma CA. 03 2019

262. 3D Volumetric Optical Coherence Tomography Angiography (OCTA) Analysis of the Progression of PED in AMD. Sonoma Eye 2019. March 03 2019

263. What is the Etiology of Intraretinal Fluid? Canadian Ophthalmic Imaging Symposium. Toronto Canada. May 2019

264. The PED Spectrum. Canadian Ophthalmic Imaging Symposium. Toronto Canada. May 2019

265. AMD vs CSR Masqueraders. Canadian Ophthalmic Imaging Symposium. Toronto Canada. May 2019

266. Vein and Artery Occlusions: Retinal Capillary Plexus and the Ischemic Cascade. Canadian Ophthalmic Imaging Symposium. Toronto Canada. May 2019

267. The Development and Progression of PED in Neovascular AMD as Told by OCT and OCTA. Atlantic Retina Conference. St Johns Newfoundland Canada. June 2019

268. The Mechanics of the Mu ̈ller Cell in Macular Disease. Atlantic Retina Conference. St Johns Newfoundland Canada. June 2019

269. OHMM Syndrome and the Importance of the Arrangement of the Retinal Capillary Plexus. Atlantic Retina Conference. St Johns Newfoundland Canada. June 2019

270. Evolution of Type 1 NV and PED in AMD: En Face OCT and OCTA 3D Volumetric Analysis. Maculart 2019. Paris France. June 2019.

271. Is The Choroid Driving CME in Retinitis Pigmentosa? Maculart 2019. Paris France. June 2019.

D. Sarraf, 07 2019, of 57

272. OHHM, PAMM, and the Ischemic Cascade. Understanding the Organization of the Retinal Capillary Plexus. EVRS Lecture Award. European VitreoRetinal Society. Lisbon Portugal. June 2019.

273. OCT Angiography: Navigating the Traps and Pitfalls of Image Interpretation. European VitreoRetinal Society. Lisbon Portugal. Keynote Lecture. June 2019.

274. OHHM Syndrome: Understanding the Organization of the Retinal Capillary Plexus. Cole Eye Institute Imaging Summit. Chicago IL. July 2019

275. CME and the Mechanics of the Muller Cell: An Advanced Retinal Imaging Analysis. Cole Eye Institute Imaging Summit. Chicago IL. July 2019

276. MOAC

NAMED AND KEYNOTE LECTURESHIPS

LuEsther T Mertz Lectureship Award, The Muller Cell: A Pivotal Player in Macular Disease. New York NY. April 2018.

Mark J Daily Lectureship Award, Is the Retinal Capillary Plexus Arranged In Series or In Parallel. Loyola University, Chicago IL. June 2018

Keynote Lecture. Pearls and Pitfalls of OCT Angiography. Toronto Ocular Imaging Symposium. Toronto ON. September 2018

Keynote Lecture. RAP: Advanced Retinal imaging of Type 3 NV. 6th International Congress on OCT Angiography and Advances in OCT. Rome Italy. December 2018

EVRS Lecture Award. PAMM and the Ischemic Cascade: Understanding the Organization of the Retinal Capillary PlexusEuropean VitreoRetinal Society. Lisbon Portugal. June 2019.

Keynote Lecture. OCT Angiography: Navigating the Traps and Pitfalls of Image Interpretation. European VitreoRetinal Society. Lisbon Portugal. Keynote Lecture. June 2019.

AWARDS/DISTINCTIONS

Dean's Honor ListUniversity of Western OntarioMay 1985, May 1986.

Louis Kagan Memorial Award for excellence in ophthalmologyUniversity of Toronto School of MedicineJune 1990

D. Sarraf, 07 2019, of 57

Association for Research and Vision in Ophthalmology/Retinal Research Foundation Award Lawrence Travel Fellowship Grant Sarraf D, Equi R, Holland G, Yoshizumi M, and Lee D. Transscleral iontophoresis of Foscarnet. Invest Ophthalmol Visual Sci. 34(4):3910, 1993.

American Board of Ophthalmology Written Examination98th percentile rankingApril 1998

Special Contribution AwardGreater LA VA Healthcare SystemJanuary 2002

UCLA Healthcare Star Certificate for excellence in patient careFebruary 2005

Jules Stein Eye Institute Faculty Teaching AwardJules Stein Eye Institute, UCLAMay 2006

King/Drew Medical Center Faculty of the Year AwardOphthalmology Department, King/Drew Medical CenterJune 2006

King/Drew Medical Center Teacher of the Year AwardOphthalmology Department, King/Drew Medical CenterJune 2006

American Academy of Ophthalmology Achievement Award.May 2007

American Academy of Ophthalmology Secretariat Award May 2008

ASRS (Association of Retinal Specialists) Honor Award August 2011

ASRS (Association of Retinal Specialists) Senior Honor AwardAugust 2014

American Academy of Ophthalmology Senior Achievement Award September 2017

Retina Atlas. Freund KB, Sarraf D, Mieler WF, Yannuzzi LA. BMA Medical Awards. Highly Commended. 09 2017.

D. Sarraf, 07 2019, of 57

MEMBERSHIPS

Medical Council of Canada May 1990 - present

Association for Research in Vision and Ophthalmology December 1991 - 1995, 1998 - 2007

American Academy of OphthalmologyAugust 1998 - present

Diplomat of the American Board of OphthalmologyJuly 1998 - present

Retina Society 03/2009 - present

Association of Retinal Specialists04/2010 - present

Macula Society12/2010 – present

Gass Club11/2011 – present

American Ophthalmology Society05/2014 – present

COMMITTEES

Interspecialty Board CommitteeAmerican Academy of OphthalmologyNovember 1999 - 2002

Ophthalmology Liasons CommitteeAmerican Academy of OphthalmologyDecember 2002 - 2009

Southern California HIV/Eye ConsortiumJuly 1999 - July 2005

Basic and Clinical Science Course Committee.American Academy of OphthalmoogyJanuary 2013 – January 2016

D. Sarraf, 07 2019, of 57

Executive BoardMacula SocietyJanuary 2014 - January 2016

Young Representative ChairMacula SocietyJanuary 2014 - January 2016

Program Committee MemberMacula SocietyJuly 2017 - present

Scientific Committee, Symposium Chair. International OCT Angiography and Advances in OCT Congress. Rome Italy. December 2016 to present

Organizing Committee. International OCT Angiography and Advances in OCT Congress. Rome Italy. December 2018 to present

Lumbroso Award Selection Committee6th International OCT Angiography and Advances in OCT CongressMay 2018 - present

BOARD MEMBERSHIP

The Macula Foundation Inc., Scientific Advisory Board Member, January 2017 to present.

Optovue Inc., Scientific Advisory Board Member, January 2016 to present.

INTRIS Board of Trustees and Executive Board, January 2017 to present.

SOCIETY MEMBERSHIPS

Co Founder and Founding Board of Trustee Member. International Retinal Imaging Society (IntRIS). January 2017 to present.

ORGANIZED CONFERENCES

Co-Director, LA Imaging Conference for Retinal Specialists (LAICRS)Doheny Eye Institute, USC and Jules Stein Eye Institute, UCLA 01/23/07, 04/24/07, 10/02/07, 02/12/08, 05/20/08, 02/10/09, 11/17/09, 02/09/10, 11/03/2010, 03/18/2011, 10/27/2011, 03/18/2012

D. Sarraf, 07 2019, of 57

Co-Director, Pacific Retina Club (PRC), Los Angeles, 04/19/2013-04/20/2013, 03/28/2014-03/29/2014, 03/27/2015, 03/18/2016, 03/26/2017, 04/21/2018, 03/15/2019

Co-Director, Internatinal Retinal Imaging Symposium (IRIS/INTRIS), Los Angeles/New York, 02/19/2013, 06/21/2014, 03/28/2015, 03/19/2016, 03/27/2016, 3/25/2017, 02/02/2018, 03/16/2019

Scientific Committee and Symposium Chair, 4th and 5th International Congress OCT Angiography and Advances in OCT. Rome Italy. December 2016 and December 2017 and December 2018

Organizing Committee, Scientific Committee, Symposium Chair. 6th International OCT Angiography and Advances in OCT Congress. Rome Italy. December 2018

Organizing Committee, Scientific Committee, Symposium Chair. 7th International OCT Angiography and Advances in OCT Congress. Rome Italy. December 2019

COURSES

Co-Director and Lecturer, JSEI/DEI Comprehensive Ophthalmology Review CourseJules Stein Eye Institute, UCLA 03/10/06-03/12/06, 03/04/07-03/06/07, 02/28/08-03/02/08, 02/26/09-03/01/09, 03/11/10-03/14/10, 02/26/11-02/28/11, 02/26/2012-02/26/2012, 03/07/2013-03/10/2013

Instructor, UCLA Clinical Fundamentals Course M201 (2nd year medical students)Jules Stein Eye Institute, UCLA 10/21/98, 04/14/99, 11/10/99, 11/29/00, 11/15/01

Instructor, UCLA Medical School Course # HBD408: Medical Neuroscienes IIGeffen School of Medicine, UCLA 01/20/11, 01/22/13

Lecturer, Internal Medicine Residency Lecture Annual SeriesDavid Geffen School of Medicine, UCLA 2001 - present

Lecturer, Annual UCLA Geriatrics Review CourseLos Angeles CA 09/19/06, 09/19/08, 09/25/09, 10/01/10, 09/21/2012, 09/21/2013, 09/11/2014

Course Instructor, Macular Disease: A Stereoscopic Journey American Academy Ophthalmology, San Francisco 11/2009, 11/2010

Senior Course Instructor, Understanding Macular Disease Through ClinicopathologicCorrelation. American Academy Ophthalmology, San Francisco 11/2010, 11/2011, 11/2012

Senior Course Instructor, The Evaluation and Management of PED in ARMD. American Academy Ophthalmology, San Francisco 11/2011, 11/2012

D. Sarraf, 07 2019, of 57

Course Instructor, Systemic Agents and Toxicity. American Academy of Ophthalmology, New Orleans 11/2013, Chicago 10/2014, Las Vegas 11/2015, Chicago 10/2016, New Orleans 11/2017, Chicago 10/2018

Course Instructor, Advanced OCT Diagnosis. American Academy of Ophthalmology, Las Vegas 11/2015, Chicago 10/2016, New Orleans 11/2017, Chicago 10/2018

Course Instructor, Mystery Macula. American Academy of Ophthalmology. Las Vegas 11/2015, Chicago 10/2016, New Orleans 11/2017, Chicago 10/2018

Course Instructor, OCT Angiography in Retinal Disease, American Academy of Ophthalmology, New Orleans 11/2017

Lecturer, DME Symposium. ASRS (San Francisco) 08/2016, AAO (Chicago) 10/2016

Lecturer, Comprehensive Ophthalmology Review Course, Stein Eye Institute, UCLA. Los Angeles 02/2016, 02/2018, 02/2019

JOURNAL EDITOR

Associate Editor, Retinal Cases and Brief Reports, January 2013 to present

Editorial Board, Ophthalmic Surgery Lasers Imaging Retina, January 2012 to present

Editorial Board, Retina, January 2015 to present

Advisory Board Member for OCT Angiography, DRCR NET, 2015 to 2016

Editorial Board, Ophthalmology at Point of Care, 2017 to present

JOURNAL REVIEWER

1. Archives of Ophthalmology 2. Biomed Central Ophthalmology3. British Journal of Ophthalmology4. Canadian Medical Association Journal5. Case Reports in Medicine6. Clinical ophthalmology7. Current Eye Research8. Eye9. Expert Opinion10.Graeffe’s Archive for Clinical and Experimental Ophthalmology11.Indian Journal of ophthalmology12.Investigative Ophthalmology and Visual Science13.Journal of the American Academy of Pediatric Ophthalmology and Strabismus14.Lasers in Surgery and Medicine

D. Sarraf, 07 2019, of 57

15.Leukemia and Lymphoma16.Molecular Vision17.Ophthalmic Lasers, Surgery, and Imaging18.Ophthalmology19.Retina20.Retina Case and Brief Reports21.Seminars in Ophthalmology22.Survey of Ophthalmology

GRANTS/PRINCIPAL INVESTIGATOR

OCT Analysis of Central Subetinal Fluid Associated with Cystoid Macular Edema. Principal Investigator David Sarraf (UCLA)

Posterior Staphyloma Imaging with Spectral Domain Optical Coherence Tomography and the Incidence of Macular Pathology. Principal Investigator David Sarraf (UCLA)

Microcystic Maculopathy Associated with Tamoxifen, Paclitaxel and Docetaxel Therapy Using Spectral Domain Optical Coherence Tomography Imaging. Principal Investigator David Sarraf (UCLA)

Retrospective SD-OCT Analysis of Patients with Macular Disease. Principal Investigator David Sarraf (UCLA)

Lucentis for Treating Submacular Vascularized PED - A Prospective Pilot Study. Genentech Study # FVF4332s Prinicipal Investigator - David Sarraf (UCLA), Clement Chan, Prema Abraham

Intravitreal aflibErcept injection for the treatment of submacular Vascularized pigmEnt epithelial detachmeNt (the EVEN Study) - Regeneron Study Principal Investigator: David Sarraf (UCLA), Clement Chan, Prema Abraham

A Phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration (The Spectri Study). Hoffmann LaRoche GX29185. Principal Investigator: David Sarraf (UCLA)

Optovue Angiography Study of Macular Disease using Spectral Domain Optical Coherence Tomography Angiography (SD-OCTA). Principal Investigator David Sarraf (UCLA)

A Randomized, Double-Masked, Active-Controlled Phase 2 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal REGN910-3 in Patients with Neovascular Age-Related Macular Degeneration (The Onyx Study). R910-3-AMD-1517. Regeneron, Inc. Principal Investigator: David Sarraf (UCLA).

D. Sarraf, 07 2019, of 57

Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration, A Phase III Clinical Trial (The Sequoia Study). 150998-006. Allergan. Principal Investigator: David Sarraf (UCLA).

Microvascular structure and morphology of neovascular membranes in age related macular degeneration (AMD) after intravitreal aflibercept injection (IAI) therapy using OCT-Angiography Analysis (The IAI-OCTA Study). Regeneron, Inc. Principal Investigator: David Sarraf (UCLA).

D. Sarraf, 07 2019, of 57

· Web viewImpact of OCTA on our Understanding of AMD: Biology and Management. UCLA Stein Eye...

Documents

Transcript of · Web viewImpact of OCTA on our Understanding of AMD: Biology and Management. UCLA Stein Eye...